BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-917. [PMID: 11880955 DOI: 10.1086/339202] [Cited by in Crossref: 1016] [Cited by in F6Publishing: 807] [Article Influence: 53.5] [Reference Citation Analysis]
Number Citing Articles
1 Camus V, Thibault ML, David M, Gargala G, Compagnon P, Lamoureux F, Girault C, Michot JB, Stamatoullas A, Lanic H, Jardin F, Lenain P, Tilly H, Leprêtre S. Invasive Geotrichum clavatum fungal infection in an acute myeloid leukaemia patient: a case report and review. Mycopathologia 2014;177:319-24. [PMID: 24748454 DOI: 10.1007/s11046-014-9746-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
2 Pontón J, del Palacio A. Avances y limitaciones del diagnóstico precoz de las infecciones invasoras causadas por levaduras. Revista Iberoamericana de Micología 2007;24:181-6. [DOI: 10.1016/s1130-1406(07)70041-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
3 Mariette C, Tavernier E, Hocquet D, Huynh A, Isnard F, Legrand F, Lhéritier V, Raffoux E, Dombret H, Ifrah N, Cahn J, Thiébaut A. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study. Leukemia & Lymphoma 2016;58:586-93. [DOI: 10.1080/10428194.2016.1204652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
4 Alkhazraji S, Gebremariam T, Alqarihi A, Gu Y, Mamouei Z, Singh S, Wiederhold NP, Shaw KJ, Ibrahim AS. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. Antimicrob Agents Chemother 2020;64:e01735-19. [PMID: 31818813 DOI: 10.1128/AAC.01735-19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 18.0] [Reference Citation Analysis]
5 Özen M, Dündar NO. Invasive aspergillosis in children with hematological malignancies. Expert Review of Anti-infective Therapy 2014;9:299-306. [DOI: 10.1586/eri.10.177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Leather HL, Wingard JR. Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?: . Current Opinion in Infectious Diseases 2006;19:371-9. [DOI: 10.1097/01.qco.0000235165.08797.81] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Styczynski J, Czyzewski K, Wysocki M, Gryniewicz-Kwiatkowska O, Kolodziejczyk-Gietka A, Salamonowicz M, Hutnik L, Zajac-Spychala O, Zaucha-Prazmo A, Chelmecka-Wiktorczyk L, Siewiera K, Fraczkiewicz J, Malas Z, Tomaszewska R, Irga-Jaworska N, Plonowski M, Ociepa T, Pierlejewski F, Gamrot Z, Urbanek-Dadela A, Gozdzik J, Stolpa W, Dembowska-Baginska B, Perek D, Matysiak M, Wachowiak J, Kowalczyk J, Balwierz W, Kalwak K, Chybicka A, Badowska W, Szczepanski T, Drozynska E, Krawczuk-Rybak M, Urasinski T, Mlynarski W, Woszczyk M, Karolczyk G, Sobol-Milejska G, Gil L; Polish Society of Paediatric Oncology and Haematology. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. Clin Microbiol Infect 2016;22:179.e1-179.e10. [PMID: 26493843 DOI: 10.1016/j.cmi.2015.10.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
8 Mir MA, Battiwalla M. Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Mycopathologia 2009;168:271-82. [PMID: 19156534 DOI: 10.1007/s11046-009-9181-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
9 Pawar VC, Thaker VS. In vitro efficacy of 75 essential oils against Aspergillus niger. Mycoses 2006;49:316-23. [DOI: 10.1111/j.1439-0507.2006.01241.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
10 Hageskal G, Lima N, Skaar I. The study of fungi in drinking water. Mycol Res 2009;113:165-72. [PMID: 19010414 DOI: 10.1016/j.mycres.2008.10.002] [Cited by in Crossref: 116] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
11 Köhler P, Cornely OA, Vehreschild JJ. [Fungal infections]. Internist (Berl) 2019;60:684-9. [PMID: 31119309 DOI: 10.1007/s00108-019-0618-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Cordonnier C, Maury S, Ribaud P, Kuentz M, Bassompierre F, Gluckman E, Chevret S. A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipients. Transplantation 2006;82:86-92. [PMID: 16861946 DOI: 10.1097/01.tp.0000225762.54757.f7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
13 Castagnola E, Machetti M, Bucci B, Viscoli C. Antifungal prophylaxis with azole derivatives. Clinical Microbiology and Infection 2004;10:86-95. [DOI: 10.1111/j.1470-9465.2004.00847.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
14 Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH. Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2006;12:552-9. [DOI: 10.1016/j.bbmt.2005.12.032] [Cited by in Crossref: 84] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
15 Khoshbayan A, Didehdar M, Chegini Z, Taheri F, Shariati A. A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review. J Basic Microbiol 2021;61:212-8. [PMID: 33448040 DOI: 10.1002/jobm.202000692] [Reference Citation Analysis]
16 Marfin AA, Price TH. Granulocyte Transfusion Therapy. J Intensive Care Med 2015;30:79-88. [DOI: 10.1177/0885066613498045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
17 Soubani AO. Critical care considerations of hematopoietic stem cell transplantation: . Critical Care Medicine 2006;34:S251-67. [DOI: 10.1097/01.ccm.0000231886.80470.b6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Meletiadis J, te Dorsthorst DT, Verweij PE. Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 2003;41:4718-25. [PMID: 14532210 DOI: 10.1128/JCM.41.10.4718-4725.2003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Kropshofer G, Kneer A, Edlinger M, Meister B, Salvador C, Lass-Flörl C, Freund M, Crazzolara R. Computed tomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients. Pediatr Blood Cancer 2014;61:1620-4. [PMID: 24803392 DOI: 10.1002/pbc.25091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
20 Osorio JJ, Román AR, Torre-Cisneros J. [Spectrum and risk factors of invasive fungal infection]. Enferm Infecc Microbiol Clin 2007;25:467-76. [PMID: 17692214 DOI: 10.1157/13108710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
21 Li Z, Lu G, Meng G. Pathogenic Fungal Infection in the Lung. Front Immunol 2019;10:1524. [PMID: 31333658 DOI: 10.3389/fimmu.2019.01524] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 11.5] [Reference Citation Analysis]
22 Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009;52:197-205. [PMID: 19391253 DOI: 10.1111/j.1439-0507.2009.01691.x] [Cited by in Crossref: 246] [Cited by in F6Publishing: 196] [Article Influence: 20.5] [Reference Citation Analysis]
23 Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Leppä S, Anttila V, Itälä M, Wiklund T, Remes K, Nousiainen T. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients: Fungal infections in autologous SCT recipients. European Journal of Haematology 2004;73:174-8. [DOI: 10.1111/j.1600-0609.2004.00273.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
24 Garcia-Effron G, Dilger A, Alcazar-Fuoli L, Park S, Mellado E, Perlin DS. Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J Clin Microbiol 2008;46:1200-6. [PMID: 18234874 DOI: 10.1128/JCM.02330-07] [Cited by in Crossref: 77] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
25 Rubio PM, Sevilla J, González-vicent M, Lassaletta A, Cuenca-estrella M, Díaz MA, Riesco S, Madero L. Increasing Incidence of Invasive Aspergillosis in Pediatric Hematology Oncology Patients Over the Last Decade: A Retrospective Single Centre Study. Journal of Pediatric Hematology/Oncology 2009;31:642-6. [DOI: 10.1097/mph.0b013e3181acd956] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
26 Mihu CN, King E, Yossepovitch O, Taur Y, Jakubowski A, Pamer E, Papanicolaou GA. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis 2008;10:162-7. [PMID: 17662036 DOI: 10.1111/j.1399-3062.2007.00272.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
27 Blyth CC, Gomes L, Sorrell TC, da Cruz M, Sud A, Chen SC. Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect 2011;17:306-11. [PMID: 20384699 DOI: 10.1111/j.1469-0691.2010.03231.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
28 Kim SH, Lee DG, Kwon JC, Lee HJ, Cho SY, Park C, Kwon EY, Park SH, Choi SM, Choi JH, Yoo JH. Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population. Infect Chemother 2013;45:406-14. [PMID: 24475354 DOI: 10.3947/ic.2013.45.4.406] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
29 Patterson TF. Advances and challenges in management of invasive mycoses. The Lancet 2005;366:1013-25. [DOI: 10.1016/s0140-6736(05)67381-3] [Cited by in Crossref: 160] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
30 Padmanabhan S, Battiwalla M, Hahn T, Ball D, Paplham P, Brown K, Segal BH, McCarthy P Jr, Almyroudis NG. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature. Transpl Infect Dis 2007;9:148-52. [PMID: 17462002 DOI: 10.1111/j.1399-3062.2006.00188.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Neofytos D, Fishman J, Horn D, Anaissie E, Chang C, Olyaei A, Pfaller M, Steinbach W, Webster K, Marr K. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients: Invasive fungal infections in SOT. Transplant Infectious Disease 2010;12:220-9. [DOI: 10.1111/j.1399-3062.2010.00492.x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 234] [Article Influence: 27.6] [Reference Citation Analysis]
32 Rakeman JL, Bui U, Lafe K, Chen YC, Honeycutt RJ, Cookson BT. Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J Clin Microbiol 2005;43:3324-33. [PMID: 16000456 DOI: 10.1128/JCM.43.7.3324-3333.2005] [Cited by in Crossref: 91] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
33 Leather HL, Wingard JR. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Blood Reviews 2006;20:267-87. [DOI: 10.1016/j.blre.2006.03.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
34 Herbrecht R, Caillot D, Cordonnier C, Auvrignon A, Thiebaut A, Brethon B, Michallet M, Mahlaoui N, Bertrand Y, Preziosi P, Ruiz F, Gorin N, Gangneux J. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. Journal of Antimicrobial Chemotherapy 2012;67:2731-8. [DOI: 10.1093/jac/dks266] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
35 Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Rand KH, Schain D, Baz M, Nguyen MH. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol 2007;45:1759-65. [PMID: 17428933 DOI: 10.1128/JCM.00077-07] [Cited by in Crossref: 161] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
36 Robin C, Alanio A, Cordonnier C. Mucormycosis: a new concern in the transplant ward? Curr Opin Hematol 2014;21:482-90. [PMID: 25295745 DOI: 10.1097/MOH.0000000000000082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
37 Wang ZK, Yang YS, Stefka AT, Sun G, Peng LH. Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther. 2014;39:751-766. [PMID: 24612332 DOI: 10.1111/apt.12665] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
38 Togitani K, Kobayashi M, Sakai M, Uemura Y, Taguchi H, Morita T, Sugihara S, Sano A, Nishimura K. Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malignant lymphoma after non-myeloablative allogeneic peripheral blood stem cell transplantation. Transplant Infect Dis 2007;9:137-41. [DOI: 10.1111/j.1399-3062.2007.00212.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
39 Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126-33. [PMID: 16377677 DOI: 10.1128/AAC.50.1.126-133.2006] [Cited by in Crossref: 377] [Cited by in F6Publishing: 80] [Article Influence: 25.1] [Reference Citation Analysis]
40 Horan-saullo JL, Alexander BD. Opportunistic Mycoses. Murray and Nadel's Textbook of Respiratory Medicine. Elsevier; 2016. pp. 661-681.e16. [DOI: 10.1016/b978-1-4557-3383-5.00038-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Pan AS, Srinath L. Mucormycosis in a patient with AIDS receiving systemic steroids. J Am Osteopath Assoc 2013;113:708-11. [PMID: 24005091 DOI: 10.7556/jaoa.2013.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
42 Raman Sharma R. Fungal infections of the nervous system: Current perspective and controversies in management. International Journal of Surgery 2010;8:591-601. [DOI: 10.1016/j.ijsu.2010.07.293] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
43 De La Cruz O, Silveira FP. Respiratory Fungal Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:727-39. [PMID: 29128021 DOI: 10.1016/j.ccm.2017.07.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
44 Hachem R, Bahna P, Hanna H, Stephens LC, Raad I. EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model. Antimicrob Agents Chemother 2006;50:1823-7. [PMID: 16641455 DOI: 10.1128/AAC.50.5.1823-1827.2006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
45 Chamilos G, Kontoyiannis DP. Defining the diagnosis of invasive aspergillosis. Med Mycol 2006;44:163-72. [DOI: 10.1080/13693780600823258] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
46 Soliman SSM, Baldin C, Gu Y, Singh S, Gebremariam T, Swidergall M, Alqarihi A, Youssef EG, Alkhazraji S, Pikoulas A, Perske C, Venkataramani V, Rich A, Bruno VM, Hotopp JD, Mantis NJ, Edwards JE Jr, Filler SG, Chamilos G, Vitetta ES, Ibrahim AS. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis. Nat Microbiol 2021;6:313-26. [PMID: 33462434 DOI: 10.1038/s41564-020-00837-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
47 Saliba F, Dupont B. Renal impairment and Amphotericin B formulations in patients with invasive fungal infections. Med Mycol 2008;46:97-112. [DOI: 10.1080/13693780701730469] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
48 Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50:1559-1567. [PMID: 20450350 DOI: 10.1086/652768] [Cited by in Crossref: 196] [Cited by in F6Publishing: 163] [Article Influence: 17.8] [Reference Citation Analysis]
49 Bowman JC, Abruzzo GK, Flattery AM, Gill CJ, Hickey EJ, Hsu MJ, Kahn JN, Liberator PA, Misura AS, Pelak BA, Wang TC, Douglas CM. Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans. Antimicrob Agents Chemother 2006;50:4202-5. [PMID: 17015628 DOI: 10.1128/AAC.00485-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
50 Araujo R, Carneiro A, Costa-oliveira S, Pina-vaz C, Rodrigues AG, Guimaraes JE. Fungal infections after haematology unit renovation: evidence of clinical, environmental and economical impact. Eur J Haematol 2008;80:436-43. [DOI: 10.1111/j.1600-0609.2008.01034.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
51 Villaescusa T, Vázquez L, Bergua JM, García J, Romero A, Olave MT, García Belmonte D, Queipo de Llano MP; Grupo de Infecciones en pacientes hematológicos. Sociedad Andaluza de Hematología y Hemoterapia. Micafungin as antifungal prophylaxis in non-transplanted haemotological patients. Rev Esp Quimioter 2020;33:44-8. [PMID: 31865649 DOI: 10.37201/req/067.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kimura S, Oshima K, Sato K, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Nishida J, Kanda Y. Retrospective Evaluation of the Area Over the Neutrophil Curve Index to Predict Early Infection in Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation 2010;16:1355-61. [DOI: 10.1016/j.bbmt.2010.04.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
53 Kothari A, Shalin SC, Crescencio JC, Burgess MJ. Skin lesion in a patient with acute myeloid leukemia. Transpl Infect Dis 2017;19. [PMID: 27862750 DOI: 10.1111/tid.12635] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
54 Rieger CT, Ostermann H, Kolb H, Fiegl M, Huppmann S, Morgenstern N, Tischer J. A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients. Ann Hematol 2008;87:915-22. [DOI: 10.1007/s00277-008-0534-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
55 Pagano L, Valentini C, Fianchi L, Caira M. The role of neutrophils in the development and outcome of zygomycosis in haematological patients. Clinical Microbiology and Infection 2009;15:33-6. [DOI: 10.1111/j.1469-0691.2009.02977.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
56 Lau A, Chen S, Sleiman S, Sorrell T. Current status and future perspectives on molecular and serological methods in diagnostic mycology. Future Microbiology 2009;4:1185-222. [DOI: 10.2217/fmb.09.70] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
57 Hullard-pulstinger A, Holler E, Hahn J, Andreesen R, Krause SW. Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia. Onkologie 2011;34:254-8. [DOI: 10.1159/000327802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
58 Steinbach WJ, Benjamin DK, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, Lionakis MS, Torres HA, Jafri H, Walsh TJ. Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases. Clinical Infectious Diseases 2004;39:192-8. [DOI: 10.1086/421950] [Cited by in Crossref: 229] [Cited by in F6Publishing: 174] [Article Influence: 13.5] [Reference Citation Analysis]
59 Palmore TN, Shea YR, Childs RW, Sherry RM, Walsh TJ. Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification. J Clin Microbiol 2010;48:338-42. [PMID: 19923491 DOI: 10.1128/JCM.01525-09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
60 Figueiredo RT, Carneiro LA, Bozza MT. Fungal surface and innate immune recognition of filamentous fungi. Front Microbiol 2011;2:248. [PMID: 22194732 DOI: 10.3389/fmicb.2011.00248] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
61 Eiz-Vesper B, Maecker-Kolhoff B, Blasczyk R. Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry. Front Immunol 2012;3:410. [PMID: 23372567 DOI: 10.3389/fimmu.2012.00410] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
62 Campos L, Rezende SB, Simões A, Grigio GS, Fernandes PA, Macedo MCA, Silva RLD. Antimicrobial photodynamic therapy as treatment of infected oral ulcers in patients undergoing hematopoietic stem cell transplantation: Report of two cases. Photodermatol Photoimmunol Photomed 2021. [PMID: 33844343 DOI: 10.1111/phpp.12685] [Reference Citation Analysis]
63 Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL, Wang A. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol 2007;45:1811-20. [PMID: 17428932 DOI: 10.1128/JCM.00134-07] [Cited by in Crossref: 87] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
64 Rogala BG, Charpentier MM, Nguyen MK, Landolf KM, Hamad L, Gaertner KM. Oral Anticancer Therapy: Management of Drug Interactions. J Oncol Pract 2019;15:81-90. [PMID: 30763198 DOI: 10.1200/JOP.18.00483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 11.0] [Reference Citation Analysis]
65 Winn RM, Warris A, Gaustad P, Abrahamsen TG. The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium. APMIS 2007;115:1364-9. [DOI: 10.1111/j.1600-0463.2007.00719.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
66 Qabaha KI. Antimicrobial and free radical scavenging activities of five Palestinian medicinal plants. Afr J Tradit Complement Altern Med 2013;10:101-8. [PMID: 24146509 DOI: 10.4314/ajtcam.v10i4.17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
67 Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-31. [PMID: 12715306 DOI: 10.1086/374557] [Cited by in Crossref: 504] [Cited by in F6Publishing: 373] [Article Influence: 28.0] [Reference Citation Analysis]
68 Lionakis MS, Kontoyiannis DP. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer: How do the European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria apply? Cancer 2004;100:165-72. [DOI: 10.1002/cncr.11876] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
69 Nucci M, Anaissie E. Infections in Patients With Multiple Myeloma. Seminars in Hematology 2009;46:277-88. [DOI: 10.1053/j.seminhematol.2009.03.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
70 Brown J. Zygomycosis: An emerging fungal infection. American Journal of Health-System Pharmacy 2005;62:2593-6. [DOI: 10.2146/ajhp050188] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
71 López-Oviedo E, Aller AI, Martín C, Castro C, Ramirez M, Pemán JM, Cantón E, Almeida C, Martín-Mazuelos E. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method. Antimicrob Agents Chemother 2006;50:1108-11. [PMID: 16495281 DOI: 10.1128/AAC.50.3.1108-1111.2006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
72 Rieger CT, Huppmann S, Peterson L, Rieger H, Ostermann H. Classification of invasive fungal disease in patients with acute myeloid leukaemia. Mycoses 2011;54:e92-8. [PMID: 20202112 DOI: 10.1111/j.1439-0507.2009.01850.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
73 Falloon K, Juvvadi PR, Richards AD, Vargas-Muñiz JM, Renshaw H, Steinbach WJ. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus. PLoS One 2015;10:e0137869. [PMID: 26366742 DOI: 10.1371/journal.pone.0137869] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
74 Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007;139:519-31. [DOI: 10.1111/j.1365-2141.2007.06812.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
75 Beck O, Koehl U, Tramsen L, Mousset S, Latgé JP, Müller K, Schwabe D, Bader P, Klingebiel T, Lehrnbecher T. Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. J Immunol Methods 2008;335:41-5. [PMID: 18395221 DOI: 10.1016/j.jim.2008.02.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
76 Vargas-Muñiz JM, Renshaw H, Waitt G, Soderblom EJ, Moseley MA, Palmer JM, Juvvadi PR, Keller NP, Steinbach WJ. Caspofungin exposure alters the core septin AspB interactome of Aspergillus fumigatus. Biochem Biophys Res Commun 2017;485:221-6. [PMID: 28238781 DOI: 10.1016/j.bbrc.2017.02.116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Philippe B, Ibrahim-Granet O, Prévost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Van der Meeren A, Latgé JP. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003;71:3034-42. [PMID: 12761080 DOI: 10.1128/IAI.71.6.3034-3042.2003] [Cited by in Crossref: 296] [Cited by in F6Publishing: 147] [Article Influence: 16.4] [Reference Citation Analysis]
78 Gupta S, Almyroudis NG, Battiwalla M, Bambach BJ, McCarthy PL, Proefrock AD, Ball D, Paplham P, Varma A, Kwon-Chung J, Segal BH. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2007;9:156-60. [PMID: 17462004 DOI: 10.1111/j.1399-3062.2006.00189.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
79 Mariotti J, De Philippis C, Bramanti S, Sarina B, Tordato F, Pocaterra D, Casari E, Carlo-Stella C, Santoro A, Castagna L. Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide. Eur J Haematol 2019;102:357-67. [PMID: 30672611 DOI: 10.1111/ejh.13214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Leeflang MM, Debets-ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-grauls CM, Leeflang MM. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007394] [Cited by in Crossref: 83] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
81 Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments: . Current Opinion in Infectious Diseases 2004;17:517-25. [DOI: 10.1097/00001432-200412000-00003] [Cited by in Crossref: 169] [Cited by in F6Publishing: 111] [Article Influence: 9.9] [Reference Citation Analysis]
82 Tzadok R, Shapira MY, Moses AE, Or R, Block C, Strahilevitz J. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution. Mycoses 2015;58:694-8. [PMID: 26429354 DOI: 10.1111/myc.12416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
83 Narreddy S, Mellon-reppen S, Abidi M, Klein J, Peres E, Heilbrun L, Smith D, Alangaden G, Chandrasekar P. Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients. Transplant Infect Dis 2007;9:3-10. [DOI: 10.1111/j.1399-3062.2006.00172.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
84 Su T, Li H, Chen M, Gao L, Zhou F, Wang R, Zhang H, Li X, Zhao M. Invasive Pulmonary Aspergillosis in Patients With Antineutrophil Cytoplasmic Antibody Associated Vasculitis. JCR: Journal of Clinical Rheumatology 2009;15:380-2. [DOI: 10.1097/rhu.0b013e31819e67b1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Logan LK, Meltzer LA, McAuley JB, Hayden MK, Beck T, Braykov NP, Laxminarayan R, Weinstein RA; CDC Epicenters Prevention Program. Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Infections in Children: A Two-Center Case-Case-Control Study of Risk Factors and Outcomes in Chicago, Illinois. J Pediatric Infect Dis Soc 2014;3:312-9. [PMID: 26625451 DOI: 10.1093/jpids/piu011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
86 Paholcsek M, Leiter E, Markovics A, Biró S. Novel and sensitive qPCR assays for the detection and identification of aspergillosis causing species. Acta Microbiol Immunol Hung 2014;61:273-84. [PMID: 25261942 DOI: 10.1556/AMicr.61.2014.3.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 González-vicent M, Díaz M, Colmenero I, Sevilla J, Madero L. Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis. Transplant Infect Dis 2008;10:193-6. [DOI: 10.1111/j.1399-3062.2007.00288.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
88 Obata Y, Takazono T, Tashiro M, Ota Y, Wakamura T, Takahashi A, Sato K, Miyazaki T, Nishino T, Izumikawa K. The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study. Clin Exp Nephrol 2021;25:279-87. [PMID: 33179180 DOI: 10.1007/s10157-020-01989-3] [Reference Citation Analysis]
89 Rex JH, Wingard JR, Wenzel R, Herbrecht R, Sobel J, Edwards JE. The Design of Clinical Trials That Evaluate Antifungal Prophylaxis and Combination Therapy: Introduction and Overview. Clinical Infectious Diseases 2004;39:S165-9. [DOI: 10.1086/421951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
90 Gupta V, Keller A, Halliday W, Sanche S, Hassegawa W, Messner H, Kiss T, Lipton J. Cavernous sinus thrombosis presenting with diplopia in an allogeneic bone marrow transplant recipient. Am J Hematol 2004;77:77-81. [DOI: 10.1002/ajh.20145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Price TH. Granulocyte transfusion therapy. J Clin Apher 2006;21:65-71. [PMID: 16619227 DOI: 10.1002/jca.20088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
92 Kuiper L, Ruijgrok EJ. A review on the clinical use of inhaled amphotericin B. J Aerosol Med Pulm Drug Deliv 2009;22:213-27. [PMID: 19466905 DOI: 10.1089/jamp.2008.0715] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
93 La Milia DI, Vincenti S, Fiori B, Pattavina F, Torelli R, Barbara A, Wachocka M, Moscato U, Sica S, Amato V, Ricciardi W, Laurenti P. Monitoring of Particle Environmental Pollution and Fungal Isolations During Hospital Building-Work Activities in a Hematology Ward. Mediterr J Hematol Infect Dis 2019;11:e2019062. [PMID: 31700587 DOI: 10.4084/MJHID.2019.062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
94 Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003;16:607-12. [PMID: 14624113 DOI: 10.1097/00001432-200312000-00015] [Cited by in Crossref: 122] [Cited by in F6Publishing: 81] [Article Influence: 7.2] [Reference Citation Analysis]
95 Yu J, Chen Y, Fang J, Zhang K. Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review. Medicine (Baltimore) 2019;98:e16246. [PMID: 31261588 DOI: 10.1097/MD.0000000000016246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
97 Alexander B, Dodds Ashley E, Addison R, Alspaugh J, Chao N, Perfect J. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis 2006;8:13-20. [DOI: 10.1111/j.1399-3062.2006.00125.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
98 Gothard P, Rogers TR. Voriconazole for serious fungal infections. International Journal of Clinical Practice 2004;58:74-80. [DOI: 10.1111/j.1368-5031.2004.0099.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
99 Toussaint B, Lanternier F, Woloch C, Fournier D, Launay M, Billaud E, Dannaoui E, Lortholary O, Jullien V. An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples. Journal of Chromatography B 2017;1046:26-33. [DOI: 10.1016/j.jchromb.2017.01.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
100 Lehrnbecher T, Frank C, Engels K, Kriener S, Groll A, Schwabe D. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. Journal of Infection 2010;61:259-65. [DOI: 10.1016/j.jinf.2010.06.018] [Cited by in Crossref: 76] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
101 Hebart H, Klingspor L, Klingebiel T, Loeffler J, Tollemar J, Ljungman P, Wandt H, Schaefer-Eckart K, Dornbusch HJ, Meisner C, Engel C, Stenger N, Mayer T, Ringden O, Einsele H. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant 2009;43:553-61. [PMID: 19079316 DOI: 10.1038/bmt.2008.355] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 6.7] [Reference Citation Analysis]
102 Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole. Clinical Infectious Diseases 2004;39:743-6. [DOI: 10.1086/423274] [Cited by in Crossref: 318] [Cited by in F6Publishing: 240] [Article Influence: 18.7] [Reference Citation Analysis]
103 Nayak AP, Green BJ, Janotka E, Hettick JM, Friend S, Vesper SJ, Schmechel D, Beezhold DH. Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus. Clin Vaccine Immunol 2011;18:1568-76. [PMID: 21734068 DOI: 10.1128/CVI.05163-11] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
104 Gebremariam T, Wiederhold NP, Fothergill AW, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS. VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection. Antimicrob Agents Chemother 2015;59:7815-7. [PMID: 26369977 DOI: 10.1128/AAC.01437-15] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
105 Chen S, Sun KY, Feng XW, Ran X, Lama J, Ran YP. Efficacy and safety of itraconazole use in infants.World J Pediatr. 2016;12:399-407. [PMID: 27286691 DOI: 10.1007/s12519-016-0034-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
106 Salman N, Törün SH, Budan B, Somer A. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation. Expert Rev Anti Infect Ther 2011;9:307-15. [PMID: 21417870 DOI: 10.1586/eri.11.13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
107 Rivera A, Hohl T, Pamer EG. Immune Responses to Aspergillus fumigatus Infections. Biology of Blood and Marrow Transplantation 2006;12:47-9. [DOI: 10.1016/j.bbmt.2005.09.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
108 Messer SA, Diekema DJ, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, Pfaller MA. Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi. J Clin Microbiol 2007;45:1322-4. [PMID: 17267623 DOI: 10.1128/JCM.02450-06] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
109 Blyth CC, Gilroy NM, Guy SD, Chambers ST, Cheong EY, Gottlieb T, McGuinness SL, Thursky KA. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 2014;44:1333-49. [PMID: 25482744 DOI: 10.1111/imj.12598] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 9.7] [Reference Citation Analysis]
110 Cordonnier C, Ribaud P, Herbrecht R, Milpied N, Valteau-Couanet D, Morgan C, Wade A; Société Française de Greffe de Moelle et de Thérapie Cellulaire. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis 2006;42:955-63. [PMID: 16511759 DOI: 10.1086/500934] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 5.9] [Reference Citation Analysis]
111 de Fabritiis P, Spagnoli A, Di Bartolomeo P, Locasciulli A, Cudillo L, Milone G, Busca A, Picardi A, Scimè R, Bonini A, Cupelli L, Chiusolo P, Olivieri A, Santarone S, Poidomani M, Fallani S, Novelli A, Majolino I. Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection. Bone Marrow Transplant 2007;40:245-9. [DOI: 10.1038/sj.bmt.1705720] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
112 Staber P, Langner S, Dornbusch HJ, Neumeister P. Antifungal management in cancer patients. Wien Med Wochenschr 2007;157:503-10. [DOI: 10.1007/s10354-007-0466-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
113 Brownback KR, Pitts LR, Simpson SQ. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients. Mycoses 2013;56:552-8. [PMID: 23496321 DOI: 10.1111/myc.12074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
114 Sainz J, Pérez E, Gómez-Lopera S, Jurado M. IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol 2008;28:473-85. [PMID: 18484169 DOI: 10.1007/s10875-008-9197-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
115 Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents 2008;32:519-24. [PMID: 18775650 DOI: 10.1016/j.ijantimicag.2008.06.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
116 Nucci M, Anaissie E. Fungal Infections in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation—Focus on Aspergillosis. Clinics in Chest Medicine 2009;30:295-306. [DOI: 10.1016/j.ccm.2009.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
117 Abdelhakim H, Shune L, Bhatti S, Cantilena AR, Baran A, Lin TL, Ganguly S, Singh AK, Abhyankar S, Divine C, Lipe B, Mcguirk J, Allin D, Aljitawi OS. Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2019;25:1713-9. [DOI: 10.1016/j.bbmt.2019.05.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
118 Koldehoff M, Elmaagacli AH, Steckel NK, Trenschel R, Hlinka M, Ditschkowski M, Beelen DW. Successful treatment of patients with respiratory failure due to fungal infection after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2005;7:137-45. [PMID: 16390403 DOI: 10.1111/j.1399-3062.2005.00115.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
119 Chandrasekar P, Ljungman PT. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes. Transplantation 2008;86:183-91. [PMID: 18645475 DOI: 10.1097/TP.0b013e318177de64] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Montoro J, Sanz J, Lorenzo JI, Montesinos P, Rodríguez-Veiga R, Salavert M, González E, Guerreiro M, Carretero C, Balaguer A, Gómez I, Solves P, Sanz GF, Sanz MA, Piñana JL. Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen. Eur J Haematol 2019;102:331-40. [PMID: 30506598 DOI: 10.1111/ejh.13202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Panackal AA, Imhof A, Hanley EW, Marr KA. Aspergillus ustus infections among transplant recipients. Emerg Infect Dis 2006;12:403-8. [PMID: 16704776 DOI: 10.3201/eid1203.050670] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
122 Ruhil S, Kumar V, Balhara M, Malik M, Dhankhar S, Kumar M, Kumar Chhillar A. In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model). J Appl Microbiol 2014;117:643-53. [PMID: 24931000 DOI: 10.1111/jam.12576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
123 Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis 2008;21:620-5. [PMID: 18978530 DOI: 10.1097/QCO.0b013e3283165fd1] [Cited by in Crossref: 120] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
124 Lin L, Ibrahim AS, Baquir B, Fu Y, Applebaum D, Schwartz J, Wang A, Avanesian V, Spellberg B. Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. J Infect Dis 2010;201:1708-17. [PMID: 20397927 DOI: 10.1086/652496] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
125 Ezzet F, Wexler D, Courtney R, Krishna G, Lim J, Laughlin M. Oral Bioavailability of Posaconazole in Fasted Healthy Subjects: Comparison Between Three Regimens and Basis for Clinical Dosage Recommendations. Clinical Pharmacokinetics 2005;44:211-20. [DOI: 10.2165/00003088-200544020-00006] [Cited by in Crossref: 156] [Cited by in F6Publishing: 117] [Article Influence: 9.8] [Reference Citation Analysis]
126 Price TH. Granulocyte transfusion therapy: it's time for an answer. Transfusion 2006;46:1-5. [PMID: 16398722 DOI: 10.1111/j.1537-2995.2006.00693.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
127 Barnes PD, Marr KA. Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect Dis Clin North Am 2006;20:545-61, vi. [PMID: 16984868 DOI: 10.1016/j.idc.2006.06.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
128 Murali S, Langston A. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies. Transplant Infectious Disease 2009;11:480-90. [DOI: 10.1111/j.1399-3062.2009.00441.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
129 Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 2006;44:340-9. [PMID: 16455881 DOI: 10.1128/JCM.44.2.340-349.2006] [Cited by in Crossref: 126] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
130 Bouza E, Muñoz P, Guinea J. Mucormycosis: an emerging disease? Clinical Microbiology and Infection 2006;12:7-23. [DOI: 10.1111/j.1469-0691.2006.01604.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
131 Olson JA, Adler-Moore JP, Schwartz J, Jensen GM, Proffitt RT. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model. Antimicrob Agents Chemother 2006;50:2122-31. [PMID: 16723574 DOI: 10.1128/AAC.00315-06] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
132 Schwarz P, Cornely OA, Dannaoui E. Antifungal combinations in Mucorales: A microbiological perspective. Mycoses 2019;62:746-60. [PMID: 30830980 DOI: 10.1111/myc.12909] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
133 Guinea J, Jensen J, Peláez T, Gijón P, Alonso R, Rivera M, Muñoz P, Bouza E. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 2008;46:575-9. [DOI: 10.1080/13693780801978968] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
134 Olson JA, George A, Constable D, Smith P, Proffitt RT, Adler-Moore JP. Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections. Antimicrob Agents Chemother 2010;54:3884-94. [PMID: 20606065 DOI: 10.1128/AAC.01554-09] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
135 Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. Difficulties in using 1,3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysis. Journal of Medical Microbiology 2010;59:1016-22. [DOI: 10.1099/jmm.0.019299-0] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
136 Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latgé JP, Steinbach WJ. Aspergillus fumigatus and related species. Cold Spring Harb Perspect Med 2014;5:a019786. [PMID: 25377144 DOI: 10.1101/cshperspect.a019786] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 12.4] [Reference Citation Analysis]
137 Person AK, Kontoyiannis DP, Alexander BD. Fungal infections in transplant and oncology patients. Infect Dis Clin North Am 2010;24:439-59. [PMID: 20466278 DOI: 10.1016/j.idc.2010.01.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
138 Shao PL, Huang LM, Hsueh PR. Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents 2007;30:487-95. [PMID: 17961990 DOI: 10.1016/j.ijantimicag.2007.07.019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
139 Krishnan-Natesan S, Chandrasekar PH. Current and future therapeutic options in the management of invasive aspergillosis. Drugs 2008;68:265-82. [PMID: 18257606 DOI: 10.2165/00003495-200868030-00002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
140 Jones BL, McLintock LA. Impact of diagnostic markers on early antifungal therapy. Curr Opin Infect Dis 2003;16:521-6. [PMID: 14624100 DOI: 10.1097/00001432-200312000-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
141 Wiederhold NP, Lewis RE, Kontoyiannis DP. Invasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy 2003;23:1592-610. [PMID: 14695039 DOI: 10.1592/phco.23.15.1592.31965] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
142 Pfaller M, Messer S, Boyken L, Hollis R, Diekema D. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagnostic Microbiology and Infectious Disease 2003;45:241-4. [DOI: 10.1016/s0732-8893(02)00544-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
143 Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009;182:4306-12. [PMID: 19299730 DOI: 10.4049/jimmunol.0803462] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 7.6] [Reference Citation Analysis]
144 Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob Agents Chemother 2004;48:1912-5. [PMID: 15105159 DOI: 10.1128/AAC.48.5.1912-1915.2004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
145 Toma A, Fenaux P, Dreyfus F, Cordonnier C. Infections in myelodysplastic syndromes. Haematologica 2012;97:1459-70. [PMID: 22733024 DOI: 10.3324/haematol.2012.063420] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
146 Sheikhbahaei S, Mohammadi A, Sherkat R, Naeini AE, Yaran M, Najafi S. Invasive Fungal Infection in Febrile Patients with Hematologic Malignancies Undergoing Chemotherapy in Iran. Endocr Metab Immune Disord Drug Targets 2019;19:302-7. [PMID: 30747087 DOI: 10.2174/1871530319666190211163245] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
147 Ozhak-baysan B, Alastruey-izquierdo A, Saba R, Ogunc D, Ongut G, Timuragaoglu A, Arslan G, Cuenca-estrella M, Rodriguez-tudela JL. Aspergillus alliaceus and Aspergillus flavus co-infection in an acute myeloid leukemia patient. Med Mycol 2010;48:995-9. [DOI: 10.3109/13693781003749418] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
148 Özdemir N, Tüysüz G, Çelik N, Yantri L, Erginöz E, Apak H, Özkan A, Yıldız İ, Celkan T. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience. Turk Pediatri Ars 2016;51:79-86. [PMID: 27489464 DOI: 10.5152/TurkPediatriArs.2016.2757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
149 Procop GW, Roberts GD. Emerging fungal diseases: the importance of the host. Clinics in Laboratory Medicine 2004;24:691-719. [DOI: 10.1016/j.cll.2004.05.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
150 Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011;49:S7-S12. [DOI: 10.3109/13693786.2010.505204] [Cited by in Crossref: 82] [Cited by in F6Publishing: 59] [Article Influence: 8.2] [Reference Citation Analysis]
151 Cramer RA Jr, Gamcsik MP, Brooking RM, Najvar LK, Kirkpatrick WR, Patterson TF, Balibar CJ, Graybill JR, Perfect JR, Abraham SN, Steinbach WJ. Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell 2006;5:972-80. [PMID: 16757745 DOI: 10.1128/EC.00049-06] [Cited by in Crossref: 172] [Cited by in F6Publishing: 83] [Article Influence: 11.5] [Reference Citation Analysis]
152 Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM, Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A, Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S, Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S, Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A, Locasciulli A. Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biology of Blood and Marrow Transplantation 2014;20:872-80. [DOI: 10.1016/j.bbmt.2014.03.004] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 14.0] [Reference Citation Analysis]
153 Caira M, Trecarichi EM, Mancinelli M, Leone G, Pagano L. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment. Expert Rev Anti Infect Ther 2011;9:881-92. [PMID: 21810058 DOI: 10.1586/eri.11.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
154 Morrissey CO, Chen SC, Sorrell TC, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Schwarer AP, Slavin MA. Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies. Leuk Lymphoma 2011;52:179-93. [PMID: 21281234 DOI: 10.3109/10428194.2010.542600] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
155 Gebremariam T, Alkhazraji S, Alqarihi A, Wiederhold NP, Shaw KJ, Patterson TF, Filler SG, Ibrahim AS. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus. Antimicrob Agents Chemother 2020;64:e00178-20. [PMID: 32205345 DOI: 10.1128/AAC.00178-20] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 16.0] [Reference Citation Analysis]
156 Girmenia C, Barosi G, Piciocchi A, Arcese W, Aversa F, Bacigalupo A, Bandini G, Bosi A, Busca A, Castagnola E, Caselli D, Cesaro S, Ciceri F, Locasciulli A, Locatelli F, Mikulska M, Pagano L, Prete A, Raiola AM, Rambaldi A. Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biology of Blood and Marrow Transplantation 2014;20:1080-8. [DOI: 10.1016/j.bbmt.2014.02.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
157 Krueger KP, Nelson AC. Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies. Clinicoecon Outcomes Res 2009;1:35-43. [PMID: 21935305 DOI: 10.2147/ceor.s4244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
158 Schwarz P, Lortholary O, Dromer F, Dannaoui E. Carbon assimilation profiles as a tool for identification of zygomycetes. J Clin Microbiol 2007;45:1433-9. [PMID: 17329449 DOI: 10.1128/JCM.02219-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
159 Montagna MT, De Giglio O, Napoli C, Lovero G, Caggiano G, Delia M, Pastore D, Santoro N, Specchia G. Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance. Int J Mol Sci 2012;13:774-87. [PMID: 22312285 DOI: 10.3390/ijms13010774] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
160 Hamilos G, Samonis G, Kontoyiannis DP. Recent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi. Int J Microbiol 2012;2012:583792. [PMID: 22518146 DOI: 10.1155/2012/583792] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
161 Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143-1238. [PMID: 19747629 DOI: 10.1016/j.bbmt.2009.06.019] [Cited by in Crossref: 1067] [Cited by in F6Publishing: 755] [Article Influence: 88.9] [Reference Citation Analysis]
162 Pancham S, Hemmaway C, New H, Albert E, Dokal I, Roberts IAG, Mccloy M. Caspofungin for invasive fungal infections: Combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pediatric Transplantation 2005;9:254-7. [DOI: 10.1111/j.1399-3046.2005.00261.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
163 Nihtinen A, Anttila VJ, Richardson M, Meri T, Volin L, Ruutu T. The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration. Bone Marrow Transplant. 2007;40:457-460. [PMID: 17589532 DOI: 10.1038/sj.bmt.1705749] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
164 Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007;45:1161-70. [PMID: 17918077 DOI: 10.1086/522189] [Cited by in Crossref: 271] [Cited by in F6Publishing: 207] [Article Influence: 19.4] [Reference Citation Analysis]
165 Azik FM, Tezer H, Ozkaya-Parlakay A, Aksu T, Bayram C, Fettah A, Tavil B, Tunç B. Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants. J Pediatr Hematol Oncol 2015;37:e19-22. [PMID: 25522351 DOI: 10.1097/MPH.0000000000000175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
166 Neubauer W, König A, Bolek R, Trittler R, Engelhardt M, Jung M, Kümmerer K. Determination of the antifungal agent posaconazole in human serum by HPLC with parallel column-switching technique. Journal of Chromatography B 2009;877:2493-8. [DOI: 10.1016/j.jchromb.2009.06.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
167 Michallet M, Ito JI. Approaches to the Management of Invasive Fungal Infections in Hematologic Malignancy and Hematopoietic Cell Transplantation. JCO 2009;27:3398-409. [DOI: 10.1200/jco.2008.20.1178] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
168 Júnior MC, de Moraes Arantes A, Silva HM, Costa CR, Silva Mdo R. Acremonium kiliense: case report and review of published studies. Mycopathologia 2013;176:417-21. [PMID: 24002104 DOI: 10.1007/s11046-013-9700-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
169 Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007;67:1567-601. [PMID: 17661528 DOI: 10.2165/00003495-200767110-00004] [Cited by in Crossref: 260] [Cited by in F6Publishing: 179] [Article Influence: 18.6] [Reference Citation Analysis]
170 Marr KA. New approaches to invasive fungal infections: . Current Opinion in Hematology 2003;10:445-50. [DOI: 10.1097/00062752-200311000-00009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
171 Klepser M. The value of amphotericin B in the treatment of invasive fungal infections. Journal of Critical Care 2011;26:225.e1-225.e10. [DOI: 10.1016/j.jcrc.2010.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
172 Rüping MJGT, Vehreschild JJ, Cornely OA. Patients at High Risk of Invasive Fungal Infections: When and How to Treat. Drugs 2008;68:1941-62. [DOI: 10.2165/00003495-200868140-00002] [Cited by in Crossref: 157] [Cited by in F6Publishing: 126] [Article Influence: 12.1] [Reference Citation Analysis]
173 Al-gabr HM, Zheng T, Yu X. Inactivation of Aspergillus flavus in drinking water after treatment with UV irradiation followed by chlorination. Science of The Total Environment 2013;463-464:525-9. [DOI: 10.1016/j.scitotenv.2013.06.065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
174 Seagle EE, Williams SL, Chiller TM. Recent Trends in the Epidemiology of Fungal Infections. Infect Dis Clin North Am 2021;35:237-60. [PMID: 34016277 DOI: 10.1016/j.idc.2021.03.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Yılmaz G, Coşkun B, Elhan A, Azap A, Akan H. D-index: A New Scoring System in Febrile Neutropenic Patients for Predicting Invasive Fungal Infections. Turk J Haematol 2016;33:102-6. [PMID: 26376689 DOI: 10.4274/tjh.2014.0070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Ibrahim AS, Edwards JE, Filler SG, Spellberg B. Mucormycosis and Entomophthoramycosis (Zygomycosis). In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. New York: Springer; 2011. pp. 265-80. [DOI: 10.1007/978-1-4419-6640-7_15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Wingard JR. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients. Best Practice & Research Clinical Haematology 2007;20:99-107. [DOI: 10.1016/j.beha.2006.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
178 Ambasta A, Carson J, Church DL. The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients. Med Myco 2015;53:531-57. [DOI: 10.1093/mmy/myv026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
179 Kirkpatrick WR, Najvar LK, Vallor AC, Wiederhold NP, Bocanegra R, Pfeiffer J, Perkins K, Kugler AR, Sweeney TD, Patterson TF. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. Journal of Antimicrobial Chemotherapy 2012;67:970-6. [DOI: 10.1093/jac/dkr567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
180 Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, Shutt K, Pakstis DL, Zeevi A, Johnson B, Kwak EJ, Mccurry KR. Voriconazole Prophylaxis in Lung Transplant Recipients. Am J Transplant 2006;6:3008-16. [DOI: 10.1111/j.1600-6143.2006.01548.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 132] [Article Influence: 10.9] [Reference Citation Analysis]
181 Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44:531-540. [PMID: 17243056 DOI: 10.1086/510592] [Cited by in Crossref: 382] [Cited by in F6Publishing: 321] [Article Influence: 27.3] [Reference Citation Analysis]
182 Guinea J, Torres-Narbona M, Gijón P, Muñoz P, Pozo F, Peláez T, de Miguel J, Bouza E. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010;16:870-7. [PMID: 19906275 DOI: 10.1111/j.1469-0691.2009.03015.x] [Cited by in Crossref: 217] [Cited by in F6Publishing: 188] [Article Influence: 18.1] [Reference Citation Analysis]
183 Kamai Y, Lossinsky AS, Liu H, Sheppard DC, Filler SG. Polarized response of endothelial cells to invasion by Aspergillus fumigatus. Cell Microbiol 2009;11:170-82. [PMID: 19016788 DOI: 10.1111/j.1462-5822.2008.01247.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
184 Hachem R, Assaf A, Numan Y, Shah P, Jiang Y, Chaftari AM, Raad II. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents 2017;50:384-8. [PMID: 28694233 DOI: 10.1016/j.ijantimicag.2017.03.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
185 Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis 2009;15:1395-401. [PMID: 19788806 DOI: 10.3201/eid1509.090334] [Cited by in Crossref: 227] [Cited by in F6Publishing: 163] [Article Influence: 20.6] [Reference Citation Analysis]
186 Cesaro S, Giacchino M, Locatelli F, Spiller M, Buldini B, Castellini C, Caselli D, Giraldi E, Tucci F, Tridello G, Rossi MR, Castagnola E. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis 2007;7:28. [PMID: 17442100 DOI: 10.1186/1471-2334-7-28] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
187 Wirk B, Wingard JR. Current Approaches in Antifungal Prophylaxis in High Risk Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients. Mycopathologia 2009;168:299-311. [DOI: 10.1007/s11046-009-9188-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
188 Upton A, Marr KA. Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient. Curr Infect Dis Rep 2006;8:434-41. [PMID: 17064636 DOI: 10.1007/s11908-006-0017-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
189 Tricot S, Gastine T, Sendid B, Wurtz A, de Botton S, Alfandari S. [Pulmonary zygomycosis in a patient treated for invasive aspergillosis]. Med Mal Infect 2006;36:118-21. [PMID: 16458464 DOI: 10.1016/j.medmal.2005.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
190 Warris A, Verweij PE. Clinical implications of environmental sources for Aspergillus. Med Mycol 2005;43 Suppl 1:S59-65. [PMID: 16110793 DOI: 10.1080/13693780400025260] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
191 Costa SF, Alexander BD. Non-Aspergillus Fungal Pneumonia in Transplant Recipients. Clinics in Chest Medicine 2005;26:675-90. [DOI: 10.1016/j.ccm.2005.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
192 Al-gabr HM, Zheng T, Yu X. Occurrence and quantification of fungi and detection of mycotoxigenic fungi in drinking water in Xiamen City, China. Sci Total Environ 2014;466-467:1103-11. [PMID: 23391452 DOI: 10.1016/j.scitotenv.2012.12.060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
193 Suleyman G, Alangaden GJ. Nosocomial Fungal Infections. Infectious Disease Clinics of North America 2016;30:1023-52. [DOI: 10.1016/j.idc.2016.07.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
194 Ku NS, Han SH, Choi JY, Kim SB, Kim H, Jeong SJ, Kim CO, Song YG, Kim JM. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: It is less useful in non-haematological patients. Scandinavian Journal of Infectious Diseases 2012;44:600-4. [DOI: 10.3109/00365548.2012.657672] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
195 Kumari R, Palaniyandi S, Hildebrandt GC. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease. Dig Dis Sci 2019;64:669-77. [PMID: 30523482 DOI: 10.1007/s10620-018-5369-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
196 Vener C, Carrabba M, Fracchiolla NS, Costa A, Fabio G, Hu C, Sina C, Guastella C, Pignataro L, Deliliers GL. Invasive fungal sinusitis: An effective combined treatment in five haematological patients. Leukemia & Lymphoma 2009;48:1577-86. [DOI: 10.1080/10428190701457923] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
197 Hahn-Ast C, Glasmacher A, Mückter S, Schmitz A, Kraemer A, Marklein G, Brossart P, von Lilienfeld-Toal M. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother 2010;65:761-8. [PMID: 20106864 DOI: 10.1093/jac/dkp507] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
198 McCormick A, Loeffler J, Ebel F. Aspergillus fumigatus: contours of an opportunistic human pathogen. Cell Microbiol 2010;12:1535-43. [PMID: 20716206 DOI: 10.1111/j.1462-5822.2010.01517.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 78] [Article Influence: 9.3] [Reference Citation Analysis]
199 Jagannathan JP, Ramaiya N, Gill RR, Alyea EP, Ros P. Imaging of Complications of Hematopoietic Stem Cell Transplantation. Radiologic Clinics of North America 2008;46:397-417. [DOI: 10.1016/j.rcl.2008.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
200 Mehta K, Jaiswal P, Briggs F, Faubion WA, Tabibian JH, Cominelli F, Dave M. In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study. Sci Rep 2018;8:6825. [PMID: 29717163 DOI: 10.1038/s41598-018-24060-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
201 Glöckner A, Vehreschild JJ, Cornely OA. Zygomycosis ? current epidemiological aspects. Mycoses 2007;50:50-5. [DOI: 10.1111/j.1439-0507.2007.01380.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
202 Marr KA, Patterson T, Denning D. Aspergillosis. Infectious Disease Clinics of North America 2002;16:875-94. [DOI: 10.1016/s0891-5520(02)00035-1] [Cited by in Crossref: 229] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
203 Valković T, Gačić V, Ivandić J, Petrov B, Dobrila-Dintinjana R, Dadić-Hero E, Načinović-Duletić A. Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors. Turk J Haematol 2015;32:234-42. [PMID: 26376590 DOI: 10.4274/tjh.2013.0173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
204 Foshee J, Luminais C, Casey J, Farag A, Prestipino A, Iloreta AM, Nyquist G, Rosen M. An evaluation of invasive fungal sinusitis outcomes with subsite analysis and use of frozen section analysis. Int Forum Allergy Rhinol 2016;6:807-11. [PMID: 27272979 DOI: 10.1002/alr.21714] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
205 Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54 Suppl 1:S16-22. [PMID: 22247441 DOI: 10.1093/cid/cir865] [Cited by in Crossref: 238] [Cited by in F6Publishing: 159] [Article Influence: 26.4] [Reference Citation Analysis]
206 Parthasarathy A, Mantravadi PK, Kalesh K. Detectives and helpers: Natural products as resources for chemical probes and compound libraries. Pharmacol Ther 2020;216:107688. [PMID: 32980442 DOI: 10.1016/j.pharmthera.2020.107688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
207 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang C, Peck KR, Jung CW. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Journal of Infection 2016;73:496-505. [DOI: 10.1016/j.jinf.2016.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
208 Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients: Galactomannan Threshold for Diagnosing Aspergillosis. British Journal of Haematology 2004;126:852-60. [DOI: 10.1111/j.1365-2141.2004.05140.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 108] [Article Influence: 8.4] [Reference Citation Analysis]
209 Miceli MH, Perissinotti AJ, Kauffman CA, Couriel DR. Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis. Mycoses 2015;58:432-6. [DOI: 10.1111/myc.12339] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
210 Marik PE. Fungal infections in solid organ transplantation. Expert Opin Pharmacother. 2006;7:297-305. [PMID: 16448324 DOI: 10.1517/14656566.7.3.297] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
211 Bellanger A, Reboux G, Murat J, Bex V, Millon L. Detection of Aspergillus fumigatus by quantitative polymerase chain reaction in air samples impacted on low-melt agar. American Journal of Infection Control 2010;38:195-8. [DOI: 10.1016/j.ajic.2009.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
212 Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 2007;5:418-30. [PMID: 17505522 DOI: 10.1038/nrmicro1680] [Cited by in Crossref: 232] [Cited by in F6Publishing: 198] [Article Influence: 16.6] [Reference Citation Analysis]
213 Wong-beringer A, Kriengkauykiat J. Systemic Antifungal Therapy: New Options, New Challenges. Pharmacotherapy 2003;23:1441-62. [DOI: 10.1592/phco.23.14.1441.31938] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
214 Cordonnier C, Robin C, Alanio A, Bretagne S. Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing. Clin Microbiol Infect 2014;20 Suppl 6:27-35. [PMID: 24283975 DOI: 10.1111/1469-0691.12428] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
215 Akan H, Antia VP, Kouba M, Sinkó J, Tănase AD, Vrhovac R, Herbrecht R. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. J Antimicrob Chemother 2013;68 Suppl 3:iii5-16. [PMID: 24155144 DOI: 10.1093/jac/dkt389] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
216 Florescu DF, Iwen PC, Hill LA, Dumitru I, Quader MA, Kalil AC, Freifeld AG. Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clinical Transplantation 2009;23:116-20. [DOI: 10.1111/j.1399-0012.2008.00895.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
217 Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the Central Nervous System. J Fungi (Basel) 2019;5:E59. [PMID: 31288475 DOI: 10.3390/jof5030059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
218 Lass-Flörl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL. In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 2009;53:794-5. [PMID: 19064891 DOI: 10.1128/AAC.00335-08] [Cited by in Crossref: 55] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
219 Lanternier F, Sun H, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in Organ and Stem Cell Transplant Recipients. Clinical Infectious Diseases 2012;54:1-8. [DOI: 10.1093/cid/cis195] [Cited by in Crossref: 112] [Cited by in F6Publishing: 45] [Article Influence: 12.4] [Reference Citation Analysis]
220 Ibrahim AS, Edwards JE Jr, Bryant R, Spellberg B. Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol 2009;47:592-600. [PMID: 18798118 DOI: 10.1080/13693780802326001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
221 Halliday C, Hoile R, Sorrell T, James G, Yadav S, Shaw P, Bleakley M, Bradstock K, Chen S. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006;132:478-86. [PMID: 16412020 DOI: 10.1111/j.1365-2141.2005.05887.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
222 Smith WJ, Drew RH, Perfect JR. Posaconazole’s impact on prophylaxis and treatment of invasive fungal infections: an update. Expert Review of Anti-infective Therapy 2014;7:165-81. [DOI: 10.1586/14787210.7.2.165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
223 Chu S, McCormick TS, Lazarus HM, Leal LO, Ghannoum MA. Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim. Clin Immunol 2021;228:108731. [PMID: 33892201 DOI: 10.1016/j.clim.2021.108731] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Wilson DT, Drew RH, Perfect JR. Antifungal Therapy for Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Recipients: An Update. Mycopathologia 2009;168:313-27. [DOI: 10.1007/s11046-009-9193-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
225 Li CH, Cervantes M, Springer DJ, Boekhout T, Ruiz-Vazquez RM, Torres-Martinez SR, Heitman J, Lee SC. Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides. PLoS Pathog 2011;7:e1002086. [PMID: 21698218 DOI: 10.1371/journal.ppat.1002086] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
226 Krenke R, Grabczak EM. Tracheobronchial manifestations of Aspergillus infections. ScientificWorldJournal 2011;11:2310-29. [PMID: 22194666 DOI: 10.1100/2011/865239] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
227 Little JS, Cheng MP, Hsu L, Corrales CE, Marty FM. Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature. Open Forum Infect Dis 2019;6:ofz392. [PMID: 31660355 DOI: 10.1093/ofid/ofz392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Gebremariam T, Gu Y, Singh S, Kitt TM, Ibrahim AS. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis. J Antimicrob Chemother 2021:dkab233. [PMID: 34263306 DOI: 10.1093/jac/dkab233] [Reference Citation Analysis]
229 Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. The Lancet 2003;362:1828-38. [DOI: 10.1016/s0140-6736(03)14904-5] [Cited by in Crossref: 347] [Cited by in F6Publishing: 102] [Article Influence: 19.3] [Reference Citation Analysis]
230 Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M, Cordonnier C, Malak S, Guyotat D, Couderc LJ, Socié G, Milpied N, Lortholary O, Ribaud P. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect 2012;18:E396-400. [PMID: 22672535 DOI: 10.1111/j.1469-0691.2012.03908.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
231 Hovi L, Saxen H, Saarinen-pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 2007;48:28-34. [DOI: 10.1002/pbc.20717] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
232 Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother 2009;53:935-44. [PMID: 19075073 DOI: 10.1128/AAC.00751-08] [Cited by in Crossref: 155] [Cited by in F6Publishing: 50] [Article Influence: 11.9] [Reference Citation Analysis]
233 Busca A, Limerutti G, Locatelli F, Barbui A, De Rosa FG, Falda M. The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. Infection 2012;40:77-80. [DOI: 10.1007/s15010-011-0156-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
234 Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003;41:3623-6. [PMID: 12904365 DOI: 10.1128/JCM.41.8.3623-3626.2003] [Cited by in Crossref: 266] [Cited by in F6Publishing: 75] [Article Influence: 14.8] [Reference Citation Analysis]
235 Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-653. [PMID: 16080086 DOI: 10.1086/432579] [Cited by in Crossref: 1482] [Cited by in F6Publishing: 991] [Article Influence: 92.6] [Reference Citation Analysis]
236 Zaas AK, Steinbach WJ. Micafungin: the US perspective. Expert Review of Anti-infective Therapy 2014;3:183-90. [DOI: 10.1586/14787210.3.2.183] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
237 Perkhofer S, Lass-flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. International Journal of Antimicrobial Agents 2010;36:531-6. [DOI: 10.1016/j.ijantimicag.2010.08.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
238 Gallagher JC, Macdougall C, Dodds Ashley ES, Perfect JR. Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Review of Anti-infective Therapy 2014;2:253-68. [DOI: 10.1586/14787210.2.2.253] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
239 Maertens J. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies. Eur J Haematol 2007;78:275-82. [PMID: 17241370 DOI: 10.1111/j.1600-0609.2006.00805.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
240 Zhao C, Wang Q, Wang Y, Yan CH, Xu LP, Zhang XH, Liu KY, Huang XJ, Sun YQ. [Non-aspergillus molds infection after allogeneic stem cell transplantation: clinical analysis of 24 cases and outcomes]. Zhonghua Xue Ye Xue Za Zhi 2020;41:624-9. [PMID: 32942814 DOI: 10.3760/cma.j.issn.0253-2727.2020.08.002] [Reference Citation Analysis]
241 Guinea J, Peláez T, Recio S, Torres-Narbona M, Bouza E. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother 2008;52:1396-400. [PMID: 18212101 DOI: 10.1128/AAC.01512-07] [Cited by in Crossref: 158] [Cited by in F6Publishing: 61] [Article Influence: 12.2] [Reference Citation Analysis]
242 Erdemoglu Y, Aydingoz IE, Ustun C, Uzay A, Besli Y, Ozturk Durmaz E, Demirkesen C, Sahin S. Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients. J Eur Acad Dermatol Venereol 2020;34:e734-6. [PMID: 32348587 DOI: 10.1111/jdv.16551] [Reference Citation Analysis]
243 Perfect JR, Alexander BD, Schell WA. Phaeohyphomycoses (Brown-Black Moulds). In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. New York: Springer; 2011. pp. 305-17. [DOI: 10.1007/978-1-4419-6640-7_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
244 Singh N. Treatment of opportunistic mycoses: how long is long enough? Lancet Infect Dis 2003;3:703-8. [PMID: 14592599 DOI: 10.1016/s1473-3099(03)00802-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
245 Leather HL, Wingard JR. Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom? Curr Opin Infect Dis 2002;15:369-75. [PMID: 12130932 DOI: 10.1097/00001432-200208000-00003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
246 Jordanides NE, Allan EK, Mclintock LA, Copland M, Devaney M, Stewart K, Parker AN, Johnson PRE, Holyoake TL, Jones BL. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant 2005;35:389-95. [DOI: 10.1038/sj.bmt.1704768] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
247 Hansen D, Healy M, Reece K, Smith C, Woods GL. Repetitive-sequence-based PCR using the DiversiLab system for identification of Aspergillus species. J Clin Microbiol 2008;46:1835-9. [PMID: 18367576 DOI: 10.1128/JCM.00956-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
248 Ramos Amador JT, Prieto Tato L, Guillén Martín S. [Why might micafungin be the drug of choice in pediatric patients?]. Enferm Infecc Microbiol Clin 2011;29 Suppl 2:23-8. [PMID: 21420573 DOI: 10.1016/S0213-005X(11)70005-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 Mathew BP, Nath M. Recent approaches to antifungal therapy for invasive mycoses. ChemMedChem 2009;4:310-23. [PMID: 19170067 DOI: 10.1002/cmdc.200800353] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
250 Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis 2003;46:25-8. [PMID: 12742315 DOI: 10.1016/s0732-8893(03)00013-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
251 Rickerts V, Just-Nübling G, Konrad F, Kern J, Lambrecht E, Böhme A, Jacobi V, Bialek R. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006;25:8-13. [PMID: 16416267 DOI: 10.1007/s10096-005-0078-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
252 Balloy V, Sallenave JM, Wu Y, Touqui L, Latgé JP, Si-Tahar M, Chignard M. Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J Biol Chem 2008;283:30513-21. [PMID: 18703508 DOI: 10.1074/jbc.M803149200] [Cited by in Crossref: 68] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
253 Di Mambro T, Guerriero I, Aurisicchio L, Magnani M, Marra E. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses? Front Pharmacol 2019;10:80. [PMID: 30804788 DOI: 10.3389/fphar.2019.00080] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 13.5] [Reference Citation Analysis]
254 Koehler P, Salmanton-García J, Gräfe SK, Koehler FC, Mellinghoff SC, Seidel D, Steinbach A, Cornely OA. Baseline predictors influencing the prognosis of invasive aspergillosis in adults. Mycoses 2019;62:651-8. [PMID: 31066092 DOI: 10.1111/myc.12926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
255 Hong HL, Lee YM, Kim T, Lee JY, Chung YS, Kim MN, Kim SH, Choi SH, Kim YS, Woo JH, Lee SO. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother 2013;45:292-8. [PMID: 24396630 DOI: 10.3947/ic.2013.45.3.292] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
256 Partridge-hinckley K, Liddell GM, Almyroudis NG, Segal BH. Infection Control Measures to Prevent Invasive Mould Diseases in Hematopoietic Stem Cell Transplant Recipients. Mycopathologia 2009;168:329-37. [DOI: 10.1007/s11046-009-9247-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
257 Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis 2009;22:376-84. [PMID: 19491674 DOI: 10.1097/QCO.0b013e32832db9f3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
258 Pagano L, Caira M, Nosari A, Cattaneo C, Fanci R, Bonini A, Vianelli N, Garzia MG, Mancinelli M, Tosti ME, Tumbarello M, Viale P, Aversa F, Rossi G; HEMA e-Chart Group. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica 2011;96:1366-70. [PMID: 21565903 DOI: 10.3324/haematol.2011.042598] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
259 Morris MI, Villmann M. Echinocandins in the management of invasive fungal infections, part 1. American Journal of Health-System Pharmacy 2006;63:1693-703. [DOI: 10.2146/ajhp050464.p1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
260 Almyroudis NG, Kontoyiannis DP, Sepkowitz KA, Depauw BE, Walsh TJ, Segal BH. Issues Related to the Design and Interpretation of Clinical Trials of Salvage Therapy for Invasive Mold Infection. Clinical Infectious Diseases 2006;43:1449-55. [DOI: 10.1086/508455] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
261 Simitsopoulou M, Roilides E, Likartsis C, Ioannidis J, Orfanou A, Paliogianni F, Walsh TJ. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob Agents Chemother 2007;51:1048-54. [PMID: 17178797 DOI: 10.1128/AAC.01095-06] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
262 Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses 2018;61:861-7. [PMID: 30015364 DOI: 10.1111/myc.12830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
263 Penack O, Tridello G, Hoek J, Socié G, Blaise D, Passweg J, Chevallier P, Craddock C, Milpied N, Veelken H, Maertens J, Ljungman P, Cornelissen J, Thiebaut-bertrand A, Lioure B, Michallet M, Iacobelli S, Nagler A, Mohty M, Cesaro S. Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties. Bone Marrow Transplant 2016;51:418-23. [DOI: 10.1038/bmt.2015.237] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
264 Person AK, Kontoyiannis DP, Alexander BD. Fungal Infections in Transplant and Oncology Patients. Hematology/Oncology Clinics of North America 2011;25:193-213. [DOI: 10.1016/j.hoc.2010.11.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
265 McCoy D, Depestel DD, Carver PL. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts. Pharmacotherapy 2009;29:1306-25. [PMID: 19857148 DOI: 10.1592/phco.29.11.1306] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
266 Marques SA. Fungal infections of the mucous membrane. Dermatol Ther 2010;23:243-50. [PMID: 20597943 DOI: 10.1111/j.1529-8019.2010.01321.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
267 Lease ED, Alexander BD. Fungal diagnostics in pneumonia. Semin Respir Crit Care Med 2011;32:663-72. [PMID: 22167394 DOI: 10.1055/s-0031-1295714] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
268 Küpeli E, Eyüboğlu FÖ, Haberal M. Pulmonary infections in transplant recipients. Curr Opin Pulm Med 2012;18:202-12. [PMID: 22388586 DOI: 10.1097/MCP.0b013e328352104f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
269 Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Rep 2011;3:14. [PMID: 21876720 DOI: 10.3410/M3-14] [Cited by in Crossref: 130] [Cited by in F6Publishing: 62] [Article Influence: 13.0] [Reference Citation Analysis]
270 Mori T, Kato J, Yamane A, Sakurai M, Kohashi S, Kikuchi T, Ono Y, Okamoto S. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation. Int J Hematol 2012;95:564-9. [DOI: 10.1007/s12185-012-1057-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
271 Kwon DS, Mylonakis E. Posaconazole: a new broad-spectrum antifungal agent. Expert Opin Pharmacother 2007;8:1167-78. [PMID: 17516880 DOI: 10.1517/14656566.8.8.1167] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
272 Singh A, Paliwal SK, Sharma M, Mittal A, Sharma S, Sharma JP. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent. J Mol Graph Model 2016;63:1-7. [PMID: 26579619 DOI: 10.1016/j.jmgm.2015.10.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
273 Abidi MZ, D'Souza A, Kuppalli K, Ledeboer N, Hari P. CYP2C19*17 genetic polymorphism--an uncommon cause of voriconazole treatment failure. Diagn Microbiol Infect Dis 2015;83:46-8. [PMID: 25986028 DOI: 10.1016/j.diagmicrobio.2015.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
274 Gayet-Ageron A, Iten A, van Delden C, Farquet N, Masouridi-Levrat S, Von Dach E, Chalandon Y, Pittet D. In-hospital transfer is a risk factor for invasive filamentous fungal infection among hospitalized patients with hematological malignancies: a matched case-control study. Infect Control Hosp Epidemiol 2015;36:320-8. [PMID: 25695174 DOI: 10.1017/ice.2014.69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
275 Markowski J, Helbig G, Widziszowska A, Likus W, Kyrcz-Krzemień S, Jarosz U, Dziubdziela W, Markiewicz M. Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients. Med Sci Monit 2015;21:1173-80. [PMID: 25907308 DOI: 10.12659/MSM.893267] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
276 Li L, Wang J, Zhang W, Yang J, Chen L, Lv S. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: A single center study of 190 recipients. Scandinavian Journal of Infectious Diseases 2011;44:100-7. [DOI: 10.3109/00365548.2011.623311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
277 Li Y, Zhang Y, Lu L. Calcium signaling pathway is involved in non-CYP51 azole resistance in Aspergillus fumigatus. Med Mycol 2019;57:S233-8. [PMID: 30816964 DOI: 10.1093/mmy/myy075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
278 Cecil JA, Wenzel RP. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Expert Review of Hematology 2014;2:237-54. [DOI: 10.1586/ehm.09.13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
279 Bigley VH, Duarte RF, Gosling RD, Kibbler CC, Seaton S, Potter M. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant 2004;34:815-7. [PMID: 15361915 DOI: 10.1038/sj.bmt.1704660] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
280 Martos AI, Martín-mazuelos E, Romero A, Serrano C, González T, Almeida C, Puche B, Cantón E, Pemán J, Espinel-ingroff A. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp. Diagnostic Microbiology and Infectious Disease 2012;73:53-6. [DOI: 10.1016/j.diagmicrobio.2012.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
281 García-Ruiz JC, Olazábal I, Adán Pedroso RM, López-Soria L, Velasco-Benito V, Sánchez-Aparicio JA, Navajas A, Montejo M, Moragues MD. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases. Rev Iberoam Micol 2015;32:190-6. [PMID: 25936697 DOI: 10.1016/j.riam.2014.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
282 Gilman AL, Serrano A, Skelley J, Zwick D. Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant. Pediatr Blood Cancer 2006;47:959-63. [DOI: 10.1002/pbc.20572] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
283 Steinbach W, Perfect J. Scedosporium Species Infections and Treatments. Journal of Chemotherapy 2013;15:16-27. [DOI: 10.1179/joc.2003.15.supplement-2.16] [Cited by in Crossref: 51] [Cited by in F6Publishing: 12] [Article Influence: 6.4] [Reference Citation Analysis]
284 Turner MS, Drew RH, Perfect JR. Emerging echinocandins for treatment of invasive fungal infections. Expert Opin Emerg Drugs 2006;11:231-50. [PMID: 16634699 DOI: 10.1517/14728214.11.2.231] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
285 Ceesay MM, Desai SR, Berry L, Cleverley J, Kibbler CC, Pomplun S, Nicholson AG, Douiri A, Wade J, Smith M, Mufti GJ, Pagliuca A. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients. Br J Haematol 2015;168:219-29. [PMID: 25179933 DOI: 10.1111/bjh.13114] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
286 Zhang P, Jiang E, Yang D, Yan Z, Huang Y, Wei J, Wang M, Ma Q, Liu Q, Zou D, He Y, Qiu L, Feng S, Han M. Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience: Risk factors and prognosis of invasive fungal infections. Transplant Infectious Disease 2010;12:316-21. [DOI: 10.1111/j.1399-3062.2010.00497.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
287 Duarte RF, Sanchez-ortega I, Cuesta I, Arnan M, Patino B, Fernandez de Sevilla A, Gudiol C, Ayats J, Cuenca-estrella M. Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis. Clinical Infectious Diseases 2014;59:1696-702. [DOI: 10.1093/cid/ciu673] [Cited by in Crossref: 142] [Cited by in F6Publishing: 117] [Article Influence: 20.3] [Reference Citation Analysis]
288 Wen G, Zhao D, Xu X, Chen Z, Huang T, Ma J. Inactivation of fungi from four typical genera in groundwater using PMS/Cl− system: Efficacy, kinetics and mechanisms. Chemical Engineering Journal 2019;357:567-78. [DOI: 10.1016/j.cej.2018.09.195] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 17.5] [Reference Citation Analysis]
289 Morris MI. Posaconazole: A new oral antifungal agent with an expanded spectrum of activity. American Journal of Health-System Pharmacy 2009;66:225-36. [DOI: 10.2146/ajhp070532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
290 You L, Qian W, Yang Q, Mao L, Zhu L, Huang X, Jin J, Meng H. ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis. Antimicrob Agents Chemother 2017;61:e02496-16. [PMID: 28507109 DOI: 10.1128/AAC.02496-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
291 Jang SH, Colangelo PM, Gobburu JV. Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma. Clin Pharmacol Ther 2010;88:115-9. [PMID: 20505665 DOI: 10.1038/clpt.2010.64] [Cited by in Crossref: 161] [Cited by in F6Publishing: 142] [Article Influence: 14.6] [Reference Citation Analysis]
292 O'Bryan TA. Pseudallescheriasis in the 21st century. Expert Rev Anti Infect Ther 2005;3:765-73. [PMID: 16207168 DOI: 10.1586/14787210.3.5.765] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
293 Mullane K, Toor A, Kalnicky C, Rodriguez T, Klein J, Stiff P. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transplant Infect Dis 2007;9:89-96. [DOI: 10.1111/j.1399-3062.2007.00208.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
294 Hidalgo A, Parody R, Martino R, Sánchez F, Franquet T, Giménez A, Blancas C. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. European Journal of Radiology 2009;71:55-60. [DOI: 10.1016/j.ejrad.2008.03.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
295 Safdar A, Rodriguez G, Rolston KV, O'Brien S, Khouri IF, Shpall EJ, Keating MJ, Kantarjian HM, Champlin RE, Raad II, Kontoyiannis DP. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant 2007;39:157-64. [PMID: 17245424 DOI: 10.1038/sj.bmt.1705559] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
296 Mallik SK, Shahi N, Joshi N, Pant K, Kala K, Chandra S, Sarma D. The emergence of zoonotic Fusarium oxysporum infection in captive-reared fingerlings of golden mahseer, Tor putitora (Hamilton, 1822) from the central Himalayan region of India. Transbound Emerg Dis 2020;67:555-63. [PMID: 31539213 DOI: 10.1111/tbed.13367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Weinstein RA, Fridkin SK. The Changing Face of Fungal Infections in Health Care Settings. Clinical Infectious Diseases 2005;41:1455-60. [DOI: 10.1086/497138] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 5.6] [Reference Citation Analysis]
298 Weisser M, Rausch C, Droll A, Simcock M, Sendi P, Steffen I, Buitrago C, Sonnet S, Gratwohl A, Passweg J, Fluckiger U. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005;41:1143-9. [PMID: 16163633 DOI: 10.1086/444462] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
299 Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, Meis JF. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses 2014;57:97-107. [DOI: 10.1111/myc.12234] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
300 Warris A, Netea MG, Verweij PE, Gaustad P, Kullberg B, Weemaes CMR, Abrahamsen TG. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med Mycol 2005;43:613-21. [DOI: 10.1080/13693780500088333] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
301 Perfect JR. Treatment of Non-Aspergillus Moulds in Immunocompromised Patients, with Amphotericin B Lipid Complex. Clinical Infectious Diseases 2005;40:S401-8. [DOI: 10.1086/429331] [Cited by in Crossref: 117] [Cited by in F6Publishing: 71] [Article Influence: 7.3] [Reference Citation Analysis]
302 Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011;24:141-73. [PMID: 21233510 DOI: 10.1128/CMR.00027-10] [Cited by in Crossref: 296] [Cited by in F6Publishing: 101] [Article Influence: 29.6] [Reference Citation Analysis]
303 Dadwal SS, Hohl TM, Fisher CE, Boeckh M, Papanicolaou G, Carpenter PA, Fisher BT, Slavin MA, Kontoyiannis DP. American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients. Transplant Cell Ther 2021;27:201-11. [PMID: 33781516 DOI: 10.1016/j.jtct.2020.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
304 White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J Mol Diagn 2006;8:376-84. [PMID: 16825512 DOI: 10.2353/jmoldx.2006.050120] [Cited by in Crossref: 84] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
305 Lai C, Liaw S, Hsiao Y, Chiu Y, Laio W, Lee L, Hsueh P. Empyema thoracis due to Rhizopus oryzae in an allogenic bone marrow transplant recipient. Med Mycol 2006;44:75-8. [DOI: 10.1080/13693780500148392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
306 Hazar V, Karasu GT, Uygun V, Öztürk G, Kiliç SÇ, Küpesiz A, Daloglu H, Aksoylar S, Atay D, Ince EÜ, Karakükçü M, Özbek N, Tayfun F, Kansoy S, Özyürek E, Akçay A, Gürsel O, Haskologlu S, Kaya Z, Yilmaz S, Tanyeli A, Yesilipek A. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group. Med Mycol 2019;57:161-70. [PMID: 29608706 DOI: 10.1093/mmy/myy015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
307 Kojima R, Tateishi U, Kami M, Murashige N, Nannya Y, Kusumi E, Sakai M, Tanaka Y, Kanda Y, Mori S, Chiba S, Kusumoto M, Miyakoshi S, Hirai H, Taniguchi S, Sakamaki H, Takaue Y. Chest Computed Tomography of Late Invasive Aspergillosis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2005;11:506-11. [DOI: 10.1016/j.bbmt.2005.03.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
308 Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med 2015;21:260-71. [PMID: 25784246 DOI: 10.1097/MCP.0000000000000156] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
309 Dixit A, Carroll SF, Qureshi ST. Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America. Interdiscip Perspect Infect Dis 2009;2009:840452. [PMID: 19503836 DOI: 10.1155/2009/840452] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
310 Panagopoulou P, Filioti J, Farmaki E, Maloukou A, Roilides E. Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs. Infect Control Hosp Epidemiol 2007;28:60-7. [PMID: 17230389 DOI: 10.1086/508832] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
311 Espinel-Ingroff A, Canton E. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2008;46:1793-803. [PMID: 18337384 DOI: 10.1128/JCM.01883-07] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
312 Patel AK, Patel KK, Patel K, Gohel S, Chakrabarti A. Mucormycosis at a tertiary care centre in Gujarat, India. Mycoses 2017;60:407-11. [PMID: 28276102 DOI: 10.1111/myc.12610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
313 Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med. 2008;359:1766-1777. [PMID: 18946062 DOI: 10.1056/nejmoa0802629] [Cited by in Crossref: 329] [Cited by in F6Publishing: 133] [Article Influence: 25.3] [Reference Citation Analysis]
314 Zhang L, Wang M, Li R, Calderone R. Expression of Aspergillus fumigatus virulence-related genes detected in vitro and in vivo with competitive RT-PCR. Mycopathologia 2005;160:201-6. [PMID: 16205968 DOI: 10.1007/s11046-005-0141-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
315 Riwes MM, Wingard JR. Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies. Expert Rev Hematol 2012;5:661-9. [PMID: 23216596 DOI: 10.1586/ehm.12.53] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
316 Steinbach WJ, Cramer RA Jr, Perfect BZ, Henn C, Nielsen K, Heitman J, Perfect JR. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother 2007;51:2979-81. [PMID: 17502415 DOI: 10.1128/AAC.01394-06] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
317 Hicheri Y, Cook G, Cordonnier C. Antifungal prophylaxis in haematology patients: the role of voriconazole. Clinical Microbiology and Infection 2012;18:1-15. [DOI: 10.1111/j.1469-0691.2012.03772.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
318 Chamilos G, Lewis RE, Kontoyiannis DP. Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis. Fungal Genetics and Biology 2007;44:88-92. [DOI: 10.1016/j.fgb.2006.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
319 Saullo JL, Perfect JR, Alexander BD. Invasive Fungal Disease in the Transplant Population: An Overview. In: Safdar A, editor. Principles and Practice of Transplant Infectious Diseases. New York: Springer; 2019. pp. 519-41. [DOI: 10.1007/978-1-4939-9034-4_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Blennow O, Remberger M, Klingspor L, Omazic B, Fransson K, Ljungman P, Mattsson J, Ringdén O. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant 2010;45:1710-8. [DOI: 10.1038/bmt.2010.38] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
321 Krüger WH, Rüssmann B, de Wit M, Kröger N, Renges H, Sobottka I, Zander AR. Haemopoietic Cell Transplantation of Patients with a History of Deep or Invasive Fungal Infection during Prophylaxis with Liposomal Amphotericin B. Acta Haematol 2005;113:104-8. [DOI: 10.1159/000083447] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
322 Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006;44:335-42. [DOI: 10.1080/13693780500464930] [Cited by in Crossref: 147] [Cited by in F6Publishing: 112] [Article Influence: 9.8] [Reference Citation Analysis]
323 Gebremariam T, Alkhazraji S, Lin L, Wiederhold NP, Garvey EP, Hoekstra WJ, Schotzinger RJ, Patterson TF, Filler SG, Ibrahim AS. Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection. Antimicrob Agents Chemother 2017;61:e00390-17. [PMID: 28652241 DOI: 10.1128/AAC.00390-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
324 Hummel M, Spiess B, Kentouche K, Niggemann S, Böhm C, Reuter S, Kiehl M, Mörz H, Hehlmann R, Buchheidt D. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2006;44:3989-93. [PMID: 16943359 DOI: 10.1128/JCM.00466-06] [Cited by in Crossref: 58] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
325 Townsend RW, Akhtar S, Alcorn H, Berg JK, Kowalski DL, Mujais S, Desai AV. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics. Eur J Clin Pharmacol 2017;73:669-78. [PMID: 28271239 DOI: 10.1007/s00228-017-2213-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
326 Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 2011;16:1049-60. [PMID: 21659609 DOI: 10.1634/theoncologist.2010-0290] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
327 Soltani J, Moghaddam MS. Diverse and bioactive endophytic Aspergilli inhabit Cupressaceae plant family. Arch Microbiol 2014;196:635-44. [PMID: 24912659 DOI: 10.1007/s00203-014-0997-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
328 Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol 2011;3:175-91. [PMID: 21750627 DOI: 10.2147/CLEP.S12502] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
329 Legouge C, Caillot D, Chrétien M, Lafon I, Ferrant E, Audia S, Pagès P, Roques M, Estivalet L, Martin L, Maitre T, Bastie J, Dalle F. The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia? Clinical Infectious Diseases 2014;58:672-8. [DOI: 10.1093/cid/cit929] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
330 Goldschmidt P, Degorge S, Che Sarria P, Benallaoua D, Semoun O, Borderie V, Laroche L, Chaumeil C. New strategy for rapid diagnosis and characterization of fungal infections: the example of corneal scrapings. PLoS One 2012;7:e37660. [PMID: 22768289 DOI: 10.1371/journal.pone.0037660] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
331 Rubinstein SM, Culos KA, Savani B, Satyanarayana G. Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies. Bone Marrow Transplant 2018;53:123-8. [PMID: 29058698 DOI: 10.1038/bmt.2017.222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Feng Y, Guo W, Wang Y, Shi W, Liu C, Li D, Qiu Y, Shi D. Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia: A case report. WJD 2020;8:1-9. [DOI: 10.5314/wjd.v8.i1.1] [Reference Citation Analysis]
333 Chandrasekar PH, Ito JI. Amphotericin B Lipid Complex in the Management of Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Diseases 2005;40:S392-400. [DOI: 10.1086/429333] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
334 Bays DJ, Thompson GR 3rd. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients. Infect Dis Clin North Am 2019;33:545-66. [PMID: 31005138 DOI: 10.1016/j.idc.2019.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
335 Busemann C, Jülich A, Buchhold B, Schmidt V, Schneidewind L, Pink D, Schmidt CA, Neumann T, Krüger WH. Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation. J Cancer Res Clin Oncol 2017;143:2067-76. [PMID: 28551769 DOI: 10.1007/s00432-017-2446-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
336 Simms-Waldrip T, Rosen G, Nielsen-Saines K, Ikeda A, Brown B, Moore T. Invasive fungal infections in pediatric hematopoietic stem cell transplant patients. Infect Dis (Lond) 2015;47:218-24. [PMID: 25650728 DOI: 10.3109/00365548.2014.985709] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
337 Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Peláez T, Bouza E. Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital. Med Mycol 2008;46:225-30. [PMID: 18404550 DOI: 10.1080/13693780701796973] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
338 Zaas AK. Host genetics affect susceptibility to invasive aspergillosis. Med Mycol 2006;44:55-60. [DOI: 10.1080/13693780600865481] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
339 Kobayashi R, Suzuki D, Yasuda K, Kobayashi K. Itraconazole for invasive fungal infection with pediatric malignancies. Pediatr Int 2010;52:707-10. [PMID: 20337979 DOI: 10.1111/j.1442-200X.2010.03127.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
340 Bitar D, Morizot G, Van Cauteren D, Dannaoui E, Lanternier F, Lortholary O, Dromer F. Estimating the burden of mucormycosis infections in France (2005–2007) through a capture-recapture method on laboratory and administrative data. Revue d'Épidémiologie et de Santé Publique 2012;60:383-7. [DOI: 10.1016/j.respe.2012.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
341 Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J Clin Microbiol 2005;43:4943-53. [PMID: 16207946 DOI: 10.1128/JCM.43.10.4943-4953.2005] [Cited by in Crossref: 115] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
342 Gamaletsou MN, Sipsas NV, Roilides E, Walsh TJ. Rhino-Orbital-Cerebral Mucormycosis. Curr Infect Dis Rep 2012;14:423-34. [DOI: 10.1007/s11908-012-0272-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
343 Franklin JA, McCormick J, Flynn PM. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. Pediatr Infect Dis J 2003;22:747-9. [PMID: 12938676 DOI: 10.1097/01.inf.0000078164.80233.14] [Cited by in Crossref: 54] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
344 Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR. Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts. Clinical Infectious Diseases 2007;44:402-9. [DOI: 10.1086/510677] [Cited by in Crossref: 120] [Cited by in F6Publishing: 89] [Article Influence: 8.6] [Reference Citation Analysis]
345 Sandherr M, Maschmeyer G. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature. Eur J Med Res 2011;16:139-44. [PMID: 21486727 DOI: 10.1186/2047-783x-16-4-139] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
346 Mori T, Aisa Y, Kato J, Nakamura Y, Ikeda Y, Okamoto S. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole. Int J Hematol 2009;90:103-7. [DOI: 10.1007/s12185-009-0344-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
347 Segal BH, Bow EJ, Menichetti F. Fungal infections in nontransplant patients with hematologic malignancies. Infectious Disease Clinics of North America 2002;16:935-64. [DOI: 10.1016/s0891-5520(02)00043-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
348 Lehrnbecher T, Beck O, Koehl U, Tramsen L. Cultivated anti-Aspergillus T(H)1 cells. Med Mycol 2009;47 Suppl 1:S170-4. [PMID: 18651313 DOI: 10.1080/13693780802169120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
349 Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-S34. [PMID: 22247442 DOI: 10.1093/cid/cir866] [Cited by in Crossref: 565] [Cited by in F6Publishing: 366] [Article Influence: 62.8] [Reference Citation Analysis]
350 Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, Jacobs R, Dominguez EA, Tollemar JG, Baumgarten K. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221-229. [PMID: 12856215 DOI: 10.1086/375822] [Cited by in Crossref: 253] [Cited by in F6Publishing: 192] [Article Influence: 14.1] [Reference Citation Analysis]
351 Vaughn JM, Wiederhold NP, Mcconville JT, Coalson JJ, Talbert RL, Burgess DS, Johnston KP, Williams RO, Peters JI. Murine airway histology and intracellular uptake of inhaled amorphous itraconazole. International Journal of Pharmaceutics 2007;338:219-24. [DOI: 10.1016/j.ijpharm.2007.02.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
352 Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB. Invasive Fungal Infections in Pediatric Oncology Patients: 11-Year Experience at a Single Institution. Journal of Pediatric Hematology/Oncology 2005;27:135-40. [DOI: 10.1097/01.mph.0000155861.38641.ca] [Cited by in Crossref: 114] [Cited by in F6Publishing: 92] [Article Influence: 7.1] [Reference Citation Analysis]
353 Garcia A, Adedoyin G, Heitman J, Lee SC. Construction of a Recyclable Genetic Marker and Serial Gene Deletions in the Human Pathogenic Mucorales Mucor circinelloides. G3 (Bethesda) 2017;7:2047-54. [PMID: 28476909 DOI: 10.1534/g3.117.041095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
354 Neofytos D, Treadway S, Ostrander D, Alonso CD, Dierberg KL, Nussenblatt V, Durand CM, Thompson CB, Marr KA. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis 2013;15:233-42. [PMID: 23432974 DOI: 10.1111/tid.12060] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
355 White PL, Perry MD, Barnes RA. An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 2009;296:1-10. [PMID: 19416355 DOI: 10.1111/j.1574-6968.2009.01575.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
356 Issakainen J, Salonen JH, Anttila V, Koukila-kähkölä P, Castrén M, Liimatainen O, Vuento R, Ojanen T, Koivula I, Koskela M, Meurman O. Deep, respiratory tract and ear infections caused by Pseudallescheria ( Scedosporium ) and Microascus ( Scopulariopsis ) in Finland. A 10-year retrospective multi-center study. Med Mycol 2010;48:458-65. [DOI: 10.3109/13693780903161208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
357 Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004;42:5517-22. [PMID: 15583275 DOI: 10.1128/JCM.42.12.5517-5522.2004] [Cited by in Crossref: 212] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
358 Ford ES, Duke ER, Cheng GS, Yoke LM, Liu C, Hill JA, Pergam SA, Pipavath SNJ, Walter RB, Mielcarek M, Schiffer JT, Boeckh M. Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection. Transplant Cell Ther 2021;27:684.e1-9. [PMID: 33964516 DOI: 10.1016/j.jtct.2021.04.021] [Reference Citation Analysis]
359 Shorr AF, Susla GM, O'grady NP. Pulmonary Infiltrates in the Non-HIV-Infected Immunocompromised Patient. Chest 2004;125:260-71. [DOI: 10.1378/chest.125.1.260] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
360 Chandrasekar P. Diagnostic challenges and recent advances in the early management of invasive fungal infections. European Journal of Haematology 2010;84:281-90. [DOI: 10.1111/j.1600-0609.2009.01391.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
361 Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N. Efficacy of caspofungin against invasiveCandida or invasiveAspergillus infections in neutropenic patients. Cancer 2006;106:466-73. [DOI: 10.1002/cncr.21615] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
362 Ocampo J, McCormack B, Navarro E, Moreno S, Garre V, Rossi S. Protein kinase A regulatory subunit isoforms regulate growth and differentiation in Mucor circinelloides: essential role of PKAR4. Eukaryot Cell 2012;11:989-1002. [PMID: 22635921 DOI: 10.1128/EC.00017-12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
363 Bajpai VK, Khan I, Shukla S, Kumar P, Rather IA, Park Y, Huh YS, Han Y. Invasive Fungal Infections and Their Epidemiology: Measures in the Clinical Scenario. Biotechnol Bioproc E 2019;24:436-44. [DOI: 10.1007/s12257-018-0477-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
364 Cramer RA Jr, Perfect BZ, Pinchai N, Park S, Perlin DS, Asfaw YG, Heitman J, Perfect JR, Steinbach WJ. Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus. Eukaryot Cell 2008;7:1085-97. [PMID: 18456861 DOI: 10.1128/EC.00086-08] [Cited by in Crossref: 122] [Cited by in F6Publishing: 68] [Article Influence: 9.4] [Reference Citation Analysis]
365 Pitman SK, Drew RH, Perfect JR. Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations. Expert Opinion on Emerging Drugs 2011;16:559-86. [DOI: 10.1517/14728214.2011.607811] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
366 Tong KB, Lau CJ, Murtagh K, Layton AJ, Seifeldin R. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. International Journal of Infectious Diseases 2009;13:24-36. [DOI: 10.1016/j.ijid.2008.02.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
367 Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. International Journal of Clinical Practice 2004;58:612-24. [DOI: 10.1111/j.1368-5031.2004.00167.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 87] [Article Influence: 6.7] [Reference Citation Analysis]
368 Heinz WJ, Cabanillas Stanchi KM, Klinker H, Blume O, Feucht J, Hartmann U, Feuchtinger T, Lang P, Handgretinger R, Döring M. Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation. Med Mycol 2016;54:128-37. [PMID: 26483433 DOI: 10.1093/mmy/myv087] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
369 Billmyre RB, Croll D, Li W, Mieczkowski P, Carter DA, Cuomo CA, Kronstad JW, Heitman J. Highly recombinant VGII Cryptococcus gattii population develops clonal outbreak clusters through both sexual macroevolution and asexual microevolution. mBio 2014;5:e01494-14. [PMID: 25073643 DOI: 10.1128/mBio.01494-14] [Cited by in Crossref: 63] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
370 Vehreschild JJ, Rüping MJ, Steinbach A, Cornely OA. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients. Expert Opinion on Pharmacotherapy 2009;11:95-113. [DOI: 10.1517/14656560903405639] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
371 Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm 2011;419:329-38. [PMID: 21839157 DOI: 10.1016/j.ijpharm.2011.07.040] [Cited by in Crossref: 127] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
372 Hensley ME, Ke W, Hayden RT, Handgretinger R, McCullers JA. Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unit. J Pediatr Oncol Nurs 2004;21:67-78. [PMID: 15125550 DOI: 10.1177/1043454203262696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
373 Wong SSW, Rasid O, Laskaris P, Fekkar A, Cavaillon JM, Steinbach WJ, Ibrahim-Granet O. Treatment of Cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population. Virulence 2017;8:1744-52. [PMID: 28594271 DOI: 10.1080/21505594.2017.1339007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
374 West KA, Gea-Banacloche J, Stroncek D, Kadri SS. Granulocyte transfusions in the management of invasive fungal infections. Br J Haematol 2017;177:357-74. [PMID: 28295178 DOI: 10.1111/bjh.14597] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
375 Samaranayake YH, Cheung BPK, Wang Y, Yau JYY, Yeung KWS, Samaranayake LP. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production. Journal of Medical Microbiology 2013;62:303-18. [DOI: 10.1099/jmm.0.044123-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
376 Steinbach WJ, Addison RM, Mclaughlin L, Gerrald Q, Martin PL, Driscoll T, Bentsen C, Perfect JR, Alexander BD. Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients. Pediatric Infectious Disease Journal 2007;26:558-64. [DOI: 10.1097/inf.0b013e3180616cbb] [Cited by in Crossref: 86] [Cited by in F6Publishing: 15] [Article Influence: 6.1] [Reference Citation Analysis]
377 Fredricks DN, Smith C, Meier A. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol 2005;43:5122-8. [PMID: 16207973 DOI: 10.1128/JCM.43.10.5122-5128.2005] [Cited by in Crossref: 155] [Cited by in F6Publishing: 42] [Article Influence: 9.7] [Reference Citation Analysis]
378 McLintock LA, Jones BL. Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients. Br J Haematol 2004;126:289-97. [PMID: 15257700 DOI: 10.1111/j.1365-2141.2004.05031.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
379 Niaré-Doumbo S, Normand AC, Diallo YL, Dembelé AK, Thera MA, Diallo D, Piarroux R, Doumbo O, Ranque S. Preliminary study of the fungal ecology at the haematology and medical-oncology ward in Bamako, Mali. Mycopathologia 2014;178:103-9. [PMID: 24889723 DOI: 10.1007/s11046-014-9760-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
380 Johnson CM, O'Brien XM, Byrd AS, Parisi VE, Loosely AJ, Li W, Witt H, Faridi MH, LeFort CT, Gupta V, Kim M, Reichner JS. Integrin Cross-Talk Regulates the Human Neutrophil Response to Fungal β-Glucan in the Context of the Extracellular Matrix: A Prominent Role for VLA3 in the Antifungal Response. J Immunol 2017;198:318-34. [PMID: 27852744 DOI: 10.4049/jimmunol.1502381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
381 Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses: . Current Opinion in Infectious Diseases 2002;15:569-74. [DOI: 10.1097/00001432-200212000-00003] [Cited by in Crossref: 147] [Cited by in F6Publishing: 114] [Article Influence: 7.7] [Reference Citation Analysis]
382 Llata E, Blossom DB, Khoury HJ, Rao CY, Wannemuehler KA, Noble-wang J, Langston AA, Ribner BS, Lyon GM, Arnold KE, Jackson DR, Brandt ME, Chiller TM, Balajee SA, Srinivasan A, Magill SS. A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations. Diagnostic Microbiology and Infectious Disease 2011;71:72-80. [DOI: 10.1016/j.diagmicrobio.2010.12.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
383 Lin S, Liu H, Lin S, Yao M, Wu U, Kuo H, Kuo C. Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography. Anal Bioanal Chem 2012;404:217-28. [DOI: 10.1007/s00216-012-6087-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
384 Malani AN, Kauffman CA. Changing Epidemiology of Rare Mould Infections: Implications for Therapy. Drugs 2007;67:1803-12. [DOI: 10.2165/00003495-200767130-00001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 77] [Article Influence: 7.4] [Reference Citation Analysis]
385 Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R; AmBiLoad Trial Study Group. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007;44:1289-97. [PMID: 17443465 DOI: 10.1086/514341] [Cited by in Crossref: 500] [Cited by in F6Publishing: 344] [Article Influence: 35.7] [Reference Citation Analysis]
386 Taccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, Paiva JA, Blasco-Navalpotro M, De Laere E, Dimopoulos G, Rello J, Vogelaers D, Blot SI; AspICU Study Investigators. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 2015;19:7. [PMID: 25928694 DOI: 10.1186/s13054-014-0722-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 147] [Article Influence: 31.8] [Reference Citation Analysis]
387 De Pauw BE. Increasing fungal infections in the intensive care unit. Surg Infect (Larchmt) 2006;7 Suppl 2:S93-6. [PMID: 16895517 DOI: 10.1089/sur.2006.7.s2-93] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
388 Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K, Wagener MM, Singh N. Infections Due to Scedosporium apiospermum and Scedosporium prolificans in Transplant Recipients: Clinical Characteristics and Impact of Antifungal Agent Therapy on Outcome. Clinical Infectious Diseases 2005;40:89-99. [DOI: 10.1086/426445] [Cited by in Crossref: 278] [Cited by in F6Publishing: 198] [Article Influence: 17.4] [Reference Citation Analysis]
389 Chibucos MC, Soliman S, Gebremariam T, Lee H, Daugherty S, Orvis J, Shetty AC, Crabtree J, Hazen TH, Etienne KA, Kumari P, O'Connor TD, Rasko DA, Filler SG, Fraser CM, Lockhart SR, Skory CD, Ibrahim AS, Bruno VM. An integrated genomic and transcriptomic survey of mucormycosis-causing fungi. Nat Commun 2016;7:12218. [PMID: 27447865 DOI: 10.1038/ncomms12218] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 11.2] [Reference Citation Analysis]
390 Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44-69. [PMID: 15653818 DOI: 10.1128/cmr.18.1.44-69.2005] [Cited by in Crossref: 425] [Cited by in F6Publishing: 103] [Article Influence: 26.6] [Reference Citation Analysis]
391 Rapp RP. Changing Strategies for the Management of Invasive Fungal Infections. Pharmacotherapy 2004;24:4S-28S. [DOI: 10.1592/phco.24.3.4s.33151] [Cited by in Crossref: 76] [Article Influence: 4.5] [Reference Citation Analysis]
392 Tuchtan L, Piercecchi-Marti MD, Dumon H, Métras D, Léonetti G, Bartoli C. Medicolegal Implications of Nosocomial Infections: A Case Report of Aspergillus Contamination during Cardiac Surgery. J Forensic Sci 2017;62:815-8. [PMID: 28008610 DOI: 10.1111/1556-4029.13328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
393 Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol 2008;190:1605-9. [PMID: 18492913 DOI: 10.2214/AJR.07.3278] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
394 Rubin ZA, Somani J. New options for the treatment of invasive fungal infections. Seminars in Oncology 2004;31:91-8. [DOI: 10.1053/j.seminoncol.2004.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
395 Natesan SK, Lamichchane A, Swaminathan S, Wu W. Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus. Diagnostic Microbiology and Infectious Disease 2013;76:458-63. [DOI: 10.1016/j.diagmicrobio.2013.04.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
396 Ahuja J, Kanne JP. Thoracic Infections in Immunocompromised Patients. Radiologic Clinics of North America 2014;52:121-36. [DOI: 10.1016/j.rcl.2013.08.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
397 Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young JA, Bennett CL. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant 2016;51:277-82. [PMID: 26524262 DOI: 10.1038/bmt.2015.263] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
398 Avery RK. Invasive aspergillosis before HCT: safe to proceed? Bone Marrow Transplant 2016;51:346-7. [PMID: 26657833 DOI: 10.1038/bmt.2015.302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
399 Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006;2:e129. [PMID: 17196036 DOI: 10.1371/journal.ppat.0020129] [Cited by in Crossref: 183] [Cited by in F6Publishing: 158] [Article Influence: 13.1] [Reference Citation Analysis]
400 Sachdev N, Gupta P, Singh R, Chakrabarti A, Gupta V, Gupta A. BILATERAL SIMULTANEOUS ENDOGENOUS ASPERGILLUS ENDOPHTHALMITIS IN AN IMMUNOCOMPETENT PATIENT. RETINAL Cases & Brief Reports 2010;4:14-7. [DOI: 10.1097/icb.0b013e318196b26c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
401 Lepak A, Andes D. Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting. Critical Care Clinics 2011;27:123-47. [DOI: 10.1016/j.ccc.2010.11.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
402 Shapiro RS, Robbins N, Cowen LE. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 2011;75:213-67. [PMID: 21646428 DOI: 10.1128/MMBR.00045-10] [Cited by in Crossref: 334] [Cited by in F6Publishing: 148] [Article Influence: 33.4] [Reference Citation Analysis]
403 Cordonnier C, Botterel F, Maury S, Pautas C, Kuentz M, Bretagne S. New findings and key questions in hematopoietic stem cell transplantation. Med Mycol 2005;43 Suppl 1:S243-6. [PMID: 16110816 DOI: 10.1080/13693780400020022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
404 Quindós G. New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi. Clinical Microbiology and Infection 2006;12:40-52. [DOI: 10.1111/j.1469-0691.2006.01605.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
405 Ben‐ami R, Lewis R, Kontoyiannis D. Immunocompromised Hosts: Immunopharmacology of Modern Antifungals. CLIN INFECT DIS 2008;47:226-35. [DOI: 10.1086/589290] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
406 Kim SH, Yim DS, Choi SM, Kwon JC, Han S, Lee DG, Park C, Kwon EY, Park SH, Choi JH, Yoo JH. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Int J Infect Dis. 2011;15:e753-e758. [PMID: 21831685 DOI: 10.1016/j.ijid.2011.06.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
407 Kobayashi T, Lawler E, Samra H, Ford B, Sekar P. Prosthetic Finger Joint Infection Due to Aspergillus terreus. Open Forum Infect Dis 2021;8:ofaa614. [PMID: 33511236 DOI: 10.1093/ofid/ofaa614] [Reference Citation Analysis]
408 Kim SH, Park C, Kwon EY, Shin NY, Kwon JC, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. Real-time nucleic acid sequence-based amplification to predict the clinical outcome of invasive aspergillosis. J Korean Med Sci 2012;27:10-5. [PMID: 22219607 DOI: 10.3346/jkms.2012.27.1.10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
409 Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epidemiology and management options. Journal of Medical Microbiology 2006;55:809-18. [DOI: 10.1099/jmm.0.46548-0] [Cited by in Crossref: 317] [Cited by in F6Publishing: 230] [Article Influence: 21.1] [Reference Citation Analysis]
410 Lichtenstern C, Swoboda S, Hirschburger M, Domann E, Hoppe-Tichy T, Winkler M, Lass-Flörl C, Weigand MA. [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine]. Anaesthesist 2010;59:30-52. [PMID: 20082061 DOI: 10.1007/s00101-009-1655-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
411 Lionakis MS, Lewis RE, Chamilos G, Kontoyiannis DP. Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: Difficulties in Establishing Correlation Between In Vitro Susceptibility Data and the Outcome of Initial Amphotericin B Therapy. Pharmacotherapy 2005;25:1174-80. [DOI: 10.1592/phco.2005.25.9.1174] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
412 Walsh T, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clinical Microbiology and Infection 2004;10:48-66. [DOI: 10.1111/j.1470-9465.2004.00839.x] [Cited by in Crossref: 396] [Cited by in F6Publishing: 279] [Article Influence: 23.3] [Reference Citation Analysis]
413 Kikuchi T, Mori T, Yamane A, Kato J, Kohashi S, Okamoto S. Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation. Clinical Transplantation 2012;26:E544-8. [DOI: 10.1111/ctr.12016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
414 Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005;41:1242-50. [PMID: 16206097 DOI: 10.1086/496927] [Cited by in Crossref: 444] [Cited by in F6Publishing: 315] [Article Influence: 27.8] [Reference Citation Analysis]
415 Miceli MH, Lee SA. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses. 2011;54:e666-e678. [PMID: 21672045 DOI: 10.1111/j.1439-0507.2011.02032.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
416 Pfaller MA. Invasive Fungal Infections and Approaches to Their Diagnosis. Current and Emerging Technologies for the Diagnosis of Microbial Infections. Elsevier; 2015. pp. 219-87. [DOI: 10.1016/bs.mim.2015.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
417 Reed C, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008;47:364-71. [PMID: 18558882 DOI: 10.1086/589857] [Cited by in Crossref: 287] [Cited by in F6Publishing: 200] [Article Influence: 22.1] [Reference Citation Analysis]
418 Sleight BS, Chan KW, Braun TM, Serrano A, Gilman AL. Infliximab for GVHD therapy in children. Bone Marrow Transplant 2007;40:473-80. [DOI: 10.1038/sj.bmt.1705761] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
419 Safdar A, Ma J, Saliba F, Dupont B, Wingard JR, Hachem RY, Mattiuzzi GN, Chandrasekar PH, Kontoyiannis DP, Rolston KV, Walsh TJ, Champlin RE, Raad II. Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B: A Review and Meta-Analysis. Medicine 2010;89:236-44. [DOI: 10.1097/md.0b013e3181e9441b] [Cited by in Crossref: 60] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
420 Matthaiou DK, Christodoulopoulou T, Dimopoulos G. How to treat fungal infections in ICU patients. BMC Infect Dis 2015;15:205. [PMID: 25930035 DOI: 10.1186/s12879-015-0934-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
421 Chamilos G, Lewis R, Kontoyiannis D. Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis. CLIN INFECT DIS 2008;47:503-9. [DOI: 10.1086/590004] [Cited by in Crossref: 398] [Cited by in F6Publishing: 284] [Article Influence: 30.6] [Reference Citation Analysis]
422 Siwek GT, Dodgson KJ, de Margarida M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA. Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis. Clinical Infectious Diseases 2004;39:584-7. [DOI: 10.1086/422723] [Cited by in Crossref: 228] [Cited by in F6Publishing: 182] [Article Influence: 13.4] [Reference Citation Analysis]
423 Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Martin PJ, Storb RF, Marr KA. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003;102:827-33. [PMID: 12689933 DOI: 10.1182/blood-2003-02-0456] [Cited by in Crossref: 359] [Cited by in F6Publishing: 290] [Article Influence: 19.9] [Reference Citation Analysis]
424 Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005;37:246-53. [PMID: 16175901 DOI: 10.1080/00313020500099148] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
425 Antachopoulos C, Demchok JP, Roilides E, Walsh TJ. Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi. Mycoses 2010;53:321-8. [PMID: 19638003 DOI: 10.1111/j.1439-0507.2009.01725.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
426 Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE Jr, Spellberg BJ. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007;117:2649-57. [PMID: 17786247 DOI: 10.1172/JCI32338] [Cited by in Crossref: 206] [Cited by in F6Publishing: 89] [Article Influence: 14.7] [Reference Citation Analysis]
427 Safdar A, Rodriguez G, Ohmagari N, Kontoyiannis DP, Rolston KV, Raad II, Champlin RE. The safety of interferon-?-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 2005;103:731-9. [DOI: 10.1002/cncr.20883] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
428 Ullmann AJ, Cornely OA. Antifungal prophylaxis for invasive mycoses in high risk patients. Curr Opin Infect Dis 2006;19:571-6. [PMID: 17075333 DOI: 10.1097/QCO.0b013e3280108e45] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
429 Steinbach WJ, Singh N, Miller JL, Benjamin DK Jr, Schell WA, Heitman J, Perfect JR. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. Antimicrob Agents Chemother 2004;48:4922-5. [PMID: 15561883 DOI: 10.1128/AAC.48.12.4922-4925.2004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
430 Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, Tollemar JG, Dominguez EA, Yu CM, Paterson DL. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36:46-52. [PMID: 12491201 DOI: 10.1086/345441] [Cited by in Crossref: 184] [Cited by in F6Publishing: 141] [Article Influence: 9.7] [Reference Citation Analysis]
431 Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008;88:508-15. [PMID: 18982251 DOI: 10.1007/s12185-008-0184-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
432 Zaki SM, Elkholy IM, Elkady NA, Abdel-Ghany K. Mucormycosis in Cairo, Egypt: review of 10 reported cases. Med Mycol 2014;52:73-80. [PMID: 23848229 DOI: 10.3109/13693786.2013.809629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
433 Sugawara Y, Nakase K, Nakamura A, Ohishi K, Sugimoto Y, Fujieda A, Monma F, Suzuki K, Masuya M, Matsushima Y, Wada H, Nobori T, Katayama N. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Haematol 2013;90:331-9. [PMID: 23360173 DOI: 10.1111/ejh.12078] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
434 Hol JA, Wolfs TFW, Bierings MB, Lindemans CA, Versluys ABJ, Wildt de A, Gerhardt CE, Boelens JJ. Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone Marrow Transplant 2014;49:95-101. [DOI: 10.1038/bmt.2013.136] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
435 Takeda K, Suzuki J, Watanabe A, Arai T, Koiwa T, Shinfuku K, Narumoto O, Kawashima M, Fukami T, Tamura A, Nagai H, Matsui H, Kamei K. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance. Med Mycol 2021;59:327-34. [PMID: 32642756 DOI: 10.1093/mmy/myaa052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
436 Price TH. Granulocyte Transfusion: Current Status. Seminars in Hematology 2007;44:15-23. [DOI: 10.1053/j.seminhematol.2006.09.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
437 Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of Epidemiology, Diagnosis, and Treatment of Invasive Mould Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Mycopathologia 2006;162:1-15. [DOI: 10.1007/s11046-006-0025-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
438 White DA. Aspergillus pulmonary infections in transplant recipients. Clin Chest Med 2005;26:661-74, vii. [PMID: 16263404 DOI: 10.1016/j.ccm.2005.06.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
439 Bow EJ. Invasive Fungal Infection in Haematopoietic Stem Cell Transplant Recipients: Epidemiology from the Transplant Physician’s Viewpoint. Mycopathologia 2009;168:283-97. [DOI: 10.1007/s11046-009-9196-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
440 Riddell J 4th, Chenoweth CE, Kauffman CA. Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome. Mycoses 2004;47:442-6. [PMID: 15504131 DOI: 10.1111/j.1439-0507.2004.01015.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
441 Pfeiffer CD, Fine JP, Safdar N. Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis. Clinical Infectious Diseases 2006;42:1417-727. [DOI: 10.1086/503427] [Cited by in Crossref: 659] [Cited by in F6Publishing: 472] [Article Influence: 43.9] [Reference Citation Analysis]
442 Longhitano AP, Slavin MA, Harrison SJ, Teh BW. Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gap. Blood Rev 2021;49:100810. [PMID: 33676765 DOI: 10.1016/j.blre.2021.100810] [Reference Citation Analysis]
443 Chamilos G, Lionakis MS, Lewis RE, Kontoyiannis DP. Role of mini-host models in the study of medically important fungi. Lancet Infect Dis 2007;7:42-55. [PMID: 17182343 DOI: 10.1016/S1473-3099(06)70686-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
444 Prasad PA, Vaughan AM, Zaoutis TE. Trends in zygomycosis in children. Mycoses 2012;55:352-6. [PMID: 21981587 DOI: 10.1111/j.1439-0507.2011.02124.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
445 Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Gadea I, Bouza E; MYCOMED Zygomycosis Study Group. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 2007;45:2051-3. [PMID: 17392438 DOI: 10.1128/JCM.02473-06] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
446 Girmenia C, Ferretti A, Barberi W. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation. Curr Opin Hematol 2014;21:459-65. [PMID: 25295743 DOI: 10.1097/MOH.0000000000000086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
447 Pini G, Faggi E, Donato R, Sacco C, Fanci R. Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses 2008;51:117-22. [PMID: 18254747 DOI: 10.1111/j.1439-0507.2007.01453.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
448 Hagen EA, Stern H, Porter D, Duffy K, Foley K, Luger S, Schuster SJ, Stadtmauer EA, Schuster MG. High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation. CLIN INFECT DIS 2003;36:9-15. [DOI: 10.1086/344906] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
449 Vallon-Eberhard A, Makovitzki A, Beauvais A, Latgé JP, Jung S, Shai Y. Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys. Antimicrob Agents Chemother 2008;52:3118-26. [PMID: 18606837 DOI: 10.1128/AAC.00526-08] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
450 Goldschmidt P, Degorge S, Benallaoua D, Semoun O, Borsali E, Le Bouter A, Batellier L, Borderie V, Laroche L, Chaumeil C. New strategy for rapid diagnosis and characterization of keratomycosis. Ophthalmology 2012;119:945-50. [PMID: 22342013 DOI: 10.1016/j.ophtha.2011.10.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
451 Liauw CM, Slate AJ, Butler JA, Wilson-nieuwenhuis JST, Deisenroth T, Preuss A, Verran J, Whitehead KA. The Effect of Surface Hydrophobicity on the Attachment of Fungal Conidia to Substrates of Polyvinyl Acetate and Polyvinyl Alcohol. J Polym Environ 2020;28:1450-64. [DOI: 10.1007/s10924-020-01693-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
452 Gomez-Lopez A, Garcia-Effron G, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003;47:3085-8. [PMID: 14506013 DOI: 10.1128/AAC.47.10.3085-3088.2003] [Cited by in Crossref: 67] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
453 Yamaguchi M, Kurokawa T, Ishiyama K, Aoki G, Ueda M, Matano S, Takami A, Yamazaki H, Sawazaki A, Yamauchi H, Yoshida T, Nakao S. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study. Ann Hematol 2011;90:1209-17. [DOI: 10.1007/s00277-011-1277-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
454 Novicki TJ, LaFe K, Bui L, Bui U, Geise R, Marr K, Cookson BT. Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis. J Clin Microbiol 2003;41:2623-8. [PMID: 12791889 DOI: 10.1128/JCM.41.6.2623-2628.2003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
455 Ito JI, Kriengkauykiat J, Dadwal SS, Arfons LM, Lazarus HM. Approaches to the early treatment of invasive fungal infection. Leuk Lymphoma 2010;51:1623-31. [PMID: 20629521 DOI: 10.3109/10428194.2010.496504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
456 Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36:1-53. [PMID: 20088682 DOI: 10.3109/10408410903241444] [Cited by in Crossref: 612] [Cited by in F6Publishing: 459] [Article Influence: 55.6] [Reference Citation Analysis]
457 Lai C, Tan C, Huang Y, Shao P, Hsueh P. Current challenges in the management of invasive fungal infections. Journal of Infection and Chemotherapy 2008;14:77-85. [DOI: 10.1007/s10156-007-0595-7] [Cited by in Crossref: 121] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
458 Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ. Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species. J Clin Microbiol 2005;43:2092-103. [PMID: 15872227 DOI: 10.1128/JCM.43.5.2092-2103.2005] [Cited by in Crossref: 140] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
459 Jain S, Kapoor G. Invasive Aspergillosis in Children With Acute Leukemia at a Resource-limited Oncology Center. Journal of Pediatric Hematology/Oncology 2015;37:e1-5. [DOI: 10.1097/mph.0000000000000159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
460 Valle-T-Figueras JM, Renedo Miró B, Benítez Carabante MI, Díaz-de-Heredia C, Vima Bofarull J, Mendoza-Palomar N, Martín-Gómez MT, Soler-Palacín P. Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment. J Fungi (Basel) 2021;7:456. [PMID: 34200506 DOI: 10.3390/jof7060456] [Reference Citation Analysis]
461 Johnson LB, Kauffman CA. Voriconazole: A New Triazole Antifungal Agent. CLIN INFECT DIS 2003;36:630-7. [DOI: 10.1086/367933] [Cited by in Crossref: 481] [Cited by in F6Publishing: 348] [Article Influence: 26.7] [Reference Citation Analysis]
462 Slesiona S, Ibrahim-Granet O, Olias P, Brock M, Jacobsen ID. Murine infection models for Aspergillus terreus pulmonary aspergillosis reveal long-term persistence of conidia and liver degeneration. J Infect Dis 2012;205:1268-77. [PMID: 22438397 DOI: 10.1093/infdis/jis193] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
463 Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, Cappellano P, Fertrin KY, Carlesse F, Simões B, Bergamasco MD, Cunha CA, Seber A, Ribeiro MP, Queiroz-Telles F, Lee ML, Chauffaille ML, Silla L, de Souza CA, Colombo AL. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013;19:745-51. [PMID: 23009319 DOI: 10.1111/1469-0691.12002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 9.2] [Reference Citation Analysis]
464 Ueda S, Miyamoto S, Kaida K, Chizuka A, Kojima R, Takano J, Ogasawara T, Miyamoto K, Miyakoshi S, Kanda Y. Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases. J Infect Chemother 2016;22:287-91. [PMID: 26908230 DOI: 10.1016/j.jiac.2016.01.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
465 Dahlin JL, Sinville R, Solberg J, Zhou H, Han J, Francis S, Strasser JM, John K, Hook DJ, Walters MA, Zhang Z. A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation. PLoS One 2013;8:e78877. [PMID: 24260132 DOI: 10.1371/journal.pone.0078877] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
466 Nagappan V, Deresinski S. Posaconazole: A Broad-Spectrum Triazole Antifungal Agent. Clinical Infectious Diseases 2007;45:1610-7. [DOI: 10.1086/523576] [Cited by in Crossref: 147] [Cited by in F6Publishing: 105] [Article Influence: 10.5] [Reference Citation Analysis]
467 Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556-569. [PMID: 16020690 DOI: 10.1128/cmr.18.3.556-569.2005] [Cited by in Crossref: 656] [Cited by in F6Publishing: 193] [Article Influence: 41.0] [Reference Citation Analysis]
468 Beck O, Topp MS, Koehl U, Roilides E, Simitsopoulou M, Hanisch M, Sarfati J, Latgé JP, Klingebiel T, Einsele H, Lehrnbecher T. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006;107:2562-9. [DOI: 10.1182/blood-2005-04-1660] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 6.0] [Reference Citation Analysis]
469 Bhabhra R, Richie DL, Kim HS, Nierman WC, Fortwendel J, Aris JP, Rhodes JC, Askew DS. Impaired ribosome biogenesis disrupts the integration between morphogenesis and nuclear duplication during the germination of Aspergillus fumigatus. Eukaryot Cell 2008;7:575-83. [PMID: 18296619 DOI: 10.1128/EC.00412-07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
470 Jansen JP, O'Sullivan AK, Lugtenburg E, Span LF, Janssen JJ, Stam WB. Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands. Ann Hematol 2010;89:919-26. [PMID: 20383504 DOI: 10.1007/s00277-010-0939-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
471 Franz P, Betat H, Mörl M. Genotyping bacterial and fungal pathogens using sequence variation in the gene for the CCA-adding enzyme. BMC Microbiol 2016;16:47. [PMID: 26987313 DOI: 10.1186/s12866-016-0670-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
472 Hayes-lattin B, Maziarz RT. Update in the Epidemiology, Prophylaxis, and Treatment of Fungal Infections in Patients with Hematologic Disorders. Leukemia & Lymphoma 2009;45:669-80. [DOI: 10.1080/10428190310001625719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
473 Hamza NS, Ghannoum MA, Lazarus HM. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004;34:377-89. [DOI: 10.1038/sj.bmt.1704603] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
474 Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, Ramos E, Jiang Y, Chaftari AM, Raad II. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother 2014;69:3148-55. [PMID: 25006241 DOI: 10.1093/jac/dku241] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
475 Kuo IF, Ensom MH. Role of therapeutic drug monitoring of voriconazole in the treatment of invasive fungal infections. Can J Hosp Pharm 2009;62:469-82. [PMID: 22478935 DOI: 10.4212/cjhp.v62i6.845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
476 Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, Kontoyiannis DP, Walsh TJ. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 2012;54 Suppl 1:S73-8. [PMID: 22247449 DOI: 10.1093/cid/cir885] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 10.4] [Reference Citation Analysis]
477 Maertens J, Glasmacher A, Selleslag D, Ngai A, Ryan D, Layton M, Taylor A, Sable C, Kartsonis N. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. Clin Infect Dis 2005;41:e9-14. [PMID: 15937754 DOI: 10.1086/430826] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
478 Tanase A, Colita A, Ianosi G, Neagoe D, Branisteanu DE, Calina D, Docea AO, Tsatsakis A, Ianosi SL. Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant. Exp Ther Med 2016;12:2078-82. [PMID: 27698695 DOI: 10.3892/etm.2016.3562] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
479 Klastersky J, Paesmans M. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Support Care Cancer 2007;15:137-41. [DOI: 10.1007/s00520-006-0137-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
480 Steinbach W. Epidemiology of invasive fungal infections in neonates and children. Clinical Microbiology and Infection 2010;16:1321-7. [DOI: 10.1111/j.1469-0691.2010.03288.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
481 O’Shea DT, Humar A. Life-threatening infection in transplant recipients. Crit Care Clin. 2013;29:953-973. [PMID: 24094386 DOI: 10.1016/j.ccc.2013.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
482 Sautour M, Dalle F, Olivieri C, L'ollivier C, Enderlin E, Salome E, Chovelon I, Vagner O, Sixt N, Fricker-Pap V, Aho S, Fontaneau O, Cachia C, Bonnin A. A prospective survey of air and surface fungal contamination in a medical mycology laboratory at a tertiary care university hospital. Am J Infect Control 2009;37:189-94. [PMID: 19059674 DOI: 10.1016/j.ajic.2008.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
483 Antachopoulos C, Roilides E. Cytokines and fungal infections. Br J Haematol 2005;129:583-96. [PMID: 15916680 DOI: 10.1111/j.1365-2141.2005.05498.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
484 Non L, Sta Cruz JP, Tuazon S. Sudden death in a patient with bone marrow transplant by a fungus among us. BMJ Case Rep 2014;2014:bcr2014207403. [PMID: 25391828 DOI: 10.1136/bcr-2014-207403] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
485 Ito JI, Chandrasekar PH, Hooshmand-rad R. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone Marrow Transplant 2005;36:873-7. [DOI: 10.1038/sj.bmt.1705143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
486 Baldin C, Soliman SSM, Jeon HH, Alkhazraji S, Gebremariam T, Gu Y, Bruno VM, Cornely OA, Leather HL, Sugrue MW, Wingard JR, Stevens DA, Edwards JE Jr, Ibrahim AS. PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis. J Clin Microbiol 2018;56:e00746-18. [PMID: 30068535 DOI: 10.1128/JCM.00746-18] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 11.3] [Reference Citation Analysis]
487 Almyroudis NG, Segal BH. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 2010;8:1451-66. [PMID: 21133669 DOI: 10.1586/eri.10.141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
488 Nir-Paz R, Strahilevitz J, Shapiro M, Keller N, Goldschmied-Reouven A, Yarden O, Block C, Polacheck I. Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel. J Clin Microbiol 2004;42:3456-61. [PMID: 15297483 DOI: 10.1128/JCM.42.8.3456-3461.2004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
489 Alastruey-izquierdo A, Alcazar-fuoli L, Cuenca-estrella M. Antifungal Susceptibility Profile of Cryptic Species of Aspergillus. Mycopathologia 2014;178:427-33. [DOI: 10.1007/s11046-014-9775-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
490 Ota Y, Obata Y, Takazono T, Tashiro M, Wakamura T, Takahashi A, Shiozawa Y, Miyazaki T, Nishino T, Izumikawa K. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study. BMC Nephrol 2021;22:240. [PMID: 34193064 DOI: 10.1186/s12882-021-02450-7] [Reference Citation Analysis]
491 Ibrahim AS, Gebremariam T, Liu M, Chamilos G, Kontoyiannis D, Mink R, Kwon-Chung KJ, Fu Y, Skory CD, Edwards JE Jr, Spellberg B. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis 2008;198:1083-90. [PMID: 18694335 DOI: 10.1086/591461] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
492 Pereira MR, Pouch SM, Scully B. Infections in Allogeneic Stem Cell Transplantation. In: Safdar A, editor. Principles and Practice of Transplant Infectious Diseases. New York: Springer; 2019. pp. 209-26. [DOI: 10.1007/978-1-4939-9034-4_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
493 Sanz Alonso M, Jarque Ramos I, Salavert Lletí M, Pemán J. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clinical Microbiology and Infection 2006;12:2-6. [DOI: 10.1111/j.1469-0691.2006.01602.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
494 Blum G, Eschertzhuber S, Auberger J, Ulmer H, Geltner C, Gastl G, Nachbaur D, Lass-flörl C. Airborne fungus exposure prior to hospitalisation as risk factor for mould infections in immunocompromised patients: Fungal exposure prior to hospitalisation. Mycoses 2012;55:237-43. [DOI: 10.1111/j.1439-0507.2011.02073.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
495 Wójtowicz A, Bochud PY. Risk stratification and immunogenetic risk for infections following stem cell transplantation. Virulence 2016;7:917-29. [PMID: 27612400 DOI: 10.1080/21505594.2016.1234566] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
496 Castagnola E, Bagnasco F, Faraci M, Caviglia I, Caruso S, Cappelli B, Moroni C, Morreale G, Timitilli A, Tripodi G, Lanino E, Haupt R. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 2008;41:339-47. [PMID: 18026151 DOI: 10.1038/sj.bmt.1705921] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
497 Luo G, Gebremariam T, Lee H, Edwards JE Jr, Kovanda L, Ibrahim AS. Isavuconazole therapy protects immunosuppressed mice from mucormycosis. Antimicrob Agents Chemother 2014;58:2450-3. [PMID: 24492363 DOI: 10.1128/AAC.02301-13] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
498 Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Martín-Dávila P, de la Cámara R, Salavert M, de la Torre J, Cisneros JM; Spanish Network for Research in Infectious Diseases. Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clin Transplant 2011;25:E629-38. [PMID: 22150886 DOI: 10.1111/j.1399-0012.2011.01495.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
499 Abdallah SM, Mohamed GG, Zayed M, El-ela MSA. Spectroscopic study of molecular structures of novel Schiff base derived from o-phthaldehyde and 2-aminophenol and its coordination compounds together with their biological activity. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2009;73:833-40. [DOI: 10.1016/j.saa.2009.04.005] [Cited by in Crossref: 127] [Cited by in F6Publishing: 33] [Article Influence: 10.6] [Reference Citation Analysis]
500 Melo AM, Stevens DA, Tell LA, Veríssimo C, Sabino R, Xavier MO. Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance. Microorganisms 2020;8:E2037. [PMID: 33352774 DOI: 10.3390/microorganisms8122037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
501 Castón-Osorio JJ, Rivero A, Torre-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents. 2008;32 Suppl 2:S103-S109. [PMID: 19013332 DOI: 10.1016/s0924-8579(08)70009-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
502 Yang W, Wiederhold NP, Williams RO. Drug delivery strategies for improved azole antifungal action. Expert Opinion on Drug Delivery 2008;5:1199-216. [DOI: 10.1517/17425240802457188] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
503 Luo G, Gebremariam T, Lee H, French SW, Wiederhold NP, Patterson TF, Filler SG, Ibrahim AS. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis. Antimicrob Agents Chemother 2013;57:3340-7. [PMID: 23650163 DOI: 10.1128/AAC.00313-13] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
504 Armenian SH, Nash KA, Kapoor N, Franklin JL, Gaynon PS, Ross LA, Hoffman JA. Prospective Monitoring for Invasive Aspergillosis Using Galactomannan and Polymerase Chain Reaction in High Risk Pediatric Patients. Journal of Pediatric Hematology/Oncology 2009;31:920-6. [DOI: 10.1097/mph.0b013e3181b83e77] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
505 Strasfeld L, Espinosa-Aguilar L, Gajewski JL, Stenzel P, Pimentel A, Mater E, Maziarz RT. Emergence of Cunninghamella as a pathogenic invasive mold infection in allogeneic transplant recipients. Clin Lymphoma Myeloma Leuk. 2013;13:622-628. [PMID: 23850285 DOI: 10.1016/j.clml.2013.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
506 Ishibashi K, Miura NN, Adachi Y, Tamura H, Tanaka S, Ohno N. The solubilization and biological activities of Aspergillus β-(1→3)-d-glucan. FEMS Immunology & Medical Microbiology 2004;42:155-66. [DOI: 10.1016/j.femsim.2004.04.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
507 Mori M. Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan. J Infect Chemother 2013;19:946-50. [PMID: 23732309 DOI: 10.1007/s10156-013-0624-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
508 Lass-Flörl C, Cuenca-Estrella M. Changes in the epidemiological landscape of invasive mould infections and disease. J Antimicrob Chemother 2017;72:i5-i11. [PMID: 28355462 DOI: 10.1093/jac/dkx028] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 12.5] [Reference Citation Analysis]
509 Cochrane JR, Mcerlean CSP, Jolliffe KA. Total Synthesis and Assignment of the Side Chain Stereochemistry of LI-F04a: An Antimicrobial Cyclic Depsipeptide. Org Lett 2010;12:3394-7. [DOI: 10.1021/ol101254m] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
510 Conen A, Weisser M, Hohler D, Frei R, Stern M. Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clinical Microbiology and Infection 2011;17:273-7. [DOI: 10.1111/j.1469-0691.2010.03266.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
511 Jantunen E, Anttila VJ, Ruutu T. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? Bone Marrow Transplant 2002;30:925-9. [PMID: 12476286 DOI: 10.1038/sj.bmt.1703738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
512 Mellado E, Cuenca-estrella M, Luis Rodríguez-tudela J. Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos. Enfermedades Infecciosas y Microbiología Clínica 2002;20:523-30. [DOI: 10.1016/s0213-005x(02)72856-5] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
513 Ibrahim AS. Host cell invasion in mucormycosis: role of iron. Curr Opin Microbiol 2011;14:406-11. [PMID: 21807554 DOI: 10.1016/j.mib.2011.07.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
514 Kim JH, Williams K. Posaconazole salvage treatment for invasive fungal infection. Mycopathologia 2014;178:259-65. [PMID: 25103141 DOI: 10.1007/s11046-014-9792-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
515 McDermott NE, Barrett J, Hipp J, Merino MJ, Richard Lee CC, Waterman P, Domingo DL, Walsh TJ. Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:e64-9. [PMID: 20219588 DOI: 10.1016/j.tripleo.2009.11.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
516 Tashiro M, Takazono T, Ota Y, Wakamura T, Takahashi A, Sato K, Miyazaki T, Obata Y, Nishino T, Izumikawa K. Efficacy of early administration of liposomal amphotericin B in patients with septic shock: A nationwide observational study. J Infect Chemother 2021;27:1471-6. [PMID: 34183236 DOI: 10.1016/j.jiac.2021.06.013] [Reference Citation Analysis]
517 Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007;45:321-46. [DOI: 10.1080/13693780701218689] [Cited by in Crossref: 453] [Cited by in F6Publishing: 356] [Article Influence: 32.4] [Reference Citation Analysis]
518 Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards JE Jr, Spellberg B. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol 2010;77:587-604. [PMID: 20545847 DOI: 10.1111/j.1365-2958.2010.07234.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 7.8] [Reference Citation Analysis]
519 Angarone M. Fungal Infections in Cancer Patients. In: Stosor V, Zembower TR, editors. Infectious Complications in Cancer Patients. Cham: Springer International Publishing; 2014. pp. 129-55. [DOI: 10.1007/978-3-319-04220-6_4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
520 Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21:157-97. [PMID: 18202441 DOI: 10.1128/CMR.00039-07] [Cited by in Crossref: 461] [Cited by in F6Publishing: 121] [Article Influence: 35.5] [Reference Citation Analysis]
521 Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011;17:1855-64. [PMID: 22000355 DOI: 10.3201/eid1710.110087] [Cited by in Crossref: 191] [Cited by in F6Publishing: 149] [Article Influence: 21.2] [Reference Citation Analysis]
522 Jo JH, Kennedy EA, Kong HH. Topographical and physiological differences of the skin mycobiome in health and disease. Virulence 2017;8:324-33. [PMID: 27754756 DOI: 10.1080/21505594.2016.1249093] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 9.6] [Reference Citation Analysis]
523 Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018;24 Suppl 1:e1-e38. [PMID: 29544767 DOI: 10.1016/j.cmi.2018.01.002] [Cited by in Crossref: 463] [Cited by in F6Publishing: 360] [Article Influence: 154.3] [Reference Citation Analysis]
524 Challa S. Pathogenesis and Pathology of Invasive Aspergillosis. Curr Fungal Infect Rep 2018;12:23-32. [DOI: 10.1007/s12281-018-0310-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
525 Neofytos D. Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:361-80. [PMID: 31005133 DOI: 10.1016/j.idc.2019.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
526 Segal BH, Kwon-Chung J, Walsh TJ, Klein BS, Battiwalla M, Almyroudis NG, Holland SM, Romani L. Immunotherapy for fungal infections. Clin Infect Dis 2006;42:507-15. [PMID: 16421795 DOI: 10.1086/499811] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
527 Nucci M, Marr KA, Queiroz-Telles F, Martins CA, Trabasso P, Costa S, Voltarelli JC, Colombo AL, Imhof A, Pasquini R, Maiolino A, Souza CA, Anaissie E. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2004;38:1237-1242. [PMID: 15127334 DOI: 10.1086/383319] [Cited by in Crossref: 222] [Cited by in F6Publishing: 154] [Article Influence: 13.1] [Reference Citation Analysis]
528 Kohno S, Izumikawa K, Kakeya H, Miyazaki Y, Ogawa K, Amitani R, Niki Y, Kurashima A. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study. Med Mycol 2011;49:688-93. [PMID: 21355713 DOI: 10.3109/13693786.2011.561369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
529 Pechlivanoglou P, Vries RD, Daenen SM, Postma MJ. Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence. PharmacoEconomics 2011;29:737-51. [DOI: 10.2165/11588370-000000000-00000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
530 Satyanarayana G. Work-up for Fever During Neutropenia for Both the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:381-97. [PMID: 31005134 DOI: 10.1016/j.idc.2019.02.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Davies-Vorbrodt S, Ito JI, Tegtmeier BR, Dadwal SS, Kriengkauykiat J. Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Pharmacotherapy 2013;33:22-30. [PMID: 23307541 DOI: 10.1002/phar.1156] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
532 Ng CK, Singhal V, Widmer F, Wright LC, Sorrell TC, Jolliffe KA. Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes. Bioorganic & Medicinal Chemistry 2007;15:3422-9. [DOI: 10.1016/j.bmc.2007.03.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
533 Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan S, Meier-kriesche H, Apewokin S, Horn DL. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. Journal of Infection 2012;65:453-64. [DOI: 10.1016/j.jinf.2012.08.003] [Cited by in Crossref: 220] [Cited by in F6Publishing: 192] [Article Influence: 24.4] [Reference Citation Analysis]
534 Gebremariam T, Alkhazraji S, Baldin C, Kovanda L, Wiederhold NP, Ibrahim AS. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis. Antimicrob Agents Chemother 2017;61:e02589-16. [PMID: 28264840 DOI: 10.1128/AAC.02589-16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
535 Magill S, Dropulic L. Antifungal prophylaxis in transplant recipients: where do we go from here? Transplant Infect Dis 2006;8:187-9. [DOI: 10.1111/j.1399-3062.2006.00181.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
536 Stuehler C, Kuenzli E, Jaeger VK, Baettig V, Ferracin F, Rajacic Z, Kaiser D, Bernardini C, Forrer P, Weisser M, Elzi L, Battegay M, Halter J, Passweg J, Khanna N. Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis. J Infect Dis 2015;212:959-67. [PMID: 25748323 DOI: 10.1093/infdis/jiv143] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
537 Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1--> 3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis. 2007;26:755-766. [PMID: 17671803 DOI: 10.1007/s10096-007-0373-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
538 Nihtinen A, Anttila V, Ruutu T, Juvonen E, Volin L. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis: AmB inhalation prophylaxis in SCT recipients. Transplant Infectious Disease 2012;14:24-32. [DOI: 10.1111/j.1399-3062.2011.00661.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
539 Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. Journal of Antimicrobial Chemotherapy 2014;69:1-11. [DOI: 10.1093/jac/dkt329] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
540 Pagano L, Valentini CG, Caira M, Fianchi L. ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. British Journal of Haematology 2009;146:597-606. [DOI: 10.1111/j.1365-2141.2009.07738.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
541 Jensen J, Guinea J, Torres-narbona M, Muñoz P, Peláez T, Bouza E. Post-surgical invasive aspergillosis: An uncommon and under-appreciated entity. Journal of Infection 2010;60:162-7. [DOI: 10.1016/j.jinf.2009.11.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
542 Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect 2014;20 Suppl 6:74-81. [PMID: 24279587 DOI: 10.1111/1469-0691.12466] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
543 Torres HA, Kontoyiannis DP. Hyalohyphomycoses (Hyaline Moulds). In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. New York: Springer; 2011. pp. 281-304. [DOI: 10.1007/978-1-4419-6640-7_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
544 Deo SS, Gottlieb DJ. Adoptive T-cell therapy for fungal infections in haematology patients. Clin Transl Immunology 2015;4:e40. [PMID: 26366286 DOI: 10.1038/cti.2015.16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
545 Shreaz S, Wani WA, Behbehani JM, Raja V, Irshad M, Karched M, Ali I, Siddiqi WA, Hun LT. Cinnamaldehyde and its derivatives, a novel class of antifungal agents. Fitoterapia 2016;112:116-31. [PMID: 27259370 DOI: 10.1016/j.fitote.2016.05.016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 50] [Article Influence: 19.6] [Reference Citation Analysis]
546 de Pauw BE. What are fungal infections? Mediterr J Hematol Infect Dis 2011;3:e2011001. [PMID: 21625304 DOI: 10.4084/MJHID.2011.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
547 Elewa H, El-mekaty E, El-bardissy A, Ensom MHH, Wilby KJ. Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review. Clin Pharmacokinet 2015;54:1223-35. [DOI: 10.1007/s40262-015-0297-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
548 Langner S, Staber PB, Neumeister P. Posaconazole in the management of refractory invasive fungal infections. Ther Clin Risk Manag 2008;4:747-58. [PMID: 19209257 DOI: 10.2147/tcrm.s3329] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
549 Tamaki M, Nozaki K, Onishi M, Yamamoto K, Ujiie H, Sugahara H. Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2016;18:601-5. [DOI: 10.1111/tid.12563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
550 Carreras E. Preventing exposure to moulds. Clinical Microbiology and Infection 2006;12:77-83. [DOI: 10.1111/j.1469-0691.2006.01608.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
551 Cortez KJ, Lyman CA, Kottilil S, Kim HS, Roilides E, Yang J, Fullmer B, Lempicki R, Walsh TJ. Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect Immun 2006;74:2353-65. [PMID: 16552065 DOI: 10.1128/IAI.74.4.2353-2365.2006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
552 Goel P, Jain V, Sengar M, Mohta A, Das P, Bansal P. Gastrointestinal mucormycosis: A success story and appraisal of concepts. Journal of Infection and Public Health 2013;6:58-61. [DOI: 10.1016/j.jiph.2012.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
553 Pagano L, Caira M. The role of primary antifungal prophylaxis in patients with haematological malignancies. Clin Microbiol Infect 2014;20 Suppl 6:19-26. [PMID: 24372659 DOI: 10.1111/1469-0691.12464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
554 Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, Lockhart SR, Christensen BE, Beer KD. A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare. J Fungi (Basel) 2019;5:E69. [PMID: 31344775 DOI: 10.3390/jof5030069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
555 Lockhart SR, Diekema DJ, Pfaller MA. The epidemiology of fungal infections. Clinical Mycology. Elsevier; 2009. pp. 1-14. [DOI: 10.1016/b978-1-4160-5680-5.00001-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
556 Ibrahim AS. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Mycoses 2014;57 Suppl 3:13-7. [PMID: 25178879 DOI: 10.1111/myc.12232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
557 Barron MA, Lay M, Madinger NE. Surgery and treatment with high-dose liposomal amphotericin B for eradication of craniofacial zygomycosis in a patient with Hodgkin's disease who had undergone allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2005;43:2012-4. [PMID: 15815047 DOI: 10.1128/JCM.43.4.2012-2014.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
558 Dvorak CC, Steinbach WJ, Brown JM, Agarwal R. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005;36:621-9. [PMID: 16044133 DOI: 10.1038/sj.bmt.1705113] [Cited by in Crossref: 94] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
559 Sheppard DC, Rieg G, Chiang LY, Filler SG, Edwards JE Jr, Ibrahim AS. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2004;48:1908-11. [PMID: 15105158 DOI: 10.1128/AAC.48.5.1908-1911.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
560 Maertens J, Theunissen K, Lodewyck T, Lagrou K, Eldere JV. Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders. Mycoses 2007;50:2-17. [DOI: 10.1111/j.1439-0507.2007.01375.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
561 Yang W, Chow KT, Lang B, Wiederhold NP, Johnston KP, Williams RO. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. European Journal of Pharmaceutical Sciences 2010;39:336-47. [DOI: 10.1016/j.ejps.2010.01.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
562 King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A. Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children. J Pediatric Infect Dis Soc 2017;6:S12-21. [PMID: 28927201 DOI: 10.1093/jpids/pix053] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
563 Leather H, Boyette RM, Tian L, Wingard JR. Pharmacokinetic Evaluation of the Drug Interaction between Intravenous Itraconazole and Intravenous Tacrolimus or Intravenous Cyclosporin A in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation 2006;12:325-34. [DOI: 10.1016/j.bbmt.2005.10.022] [Cited by in Crossref: 55] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
564 Hageskal G, Knutsen AK, Gaustad P, de Hoog GS, Skaar I. Diversity and significance of mold species in Norwegian drinking water. Appl Environ Microbiol 2006;72:7586-93. [PMID: 17028226 DOI: 10.1128/AEM.01628-06] [Cited by in Crossref: 113] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
565 Al-Rezqi A, Hawkes M, Doyle J, Richardson SE, Allen U. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review. Pediatr Transplant 2009;13:545-52. [PMID: 18992060 DOI: 10.1111/j.1399-3046.2008.01056.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
566 Chien S, Liu Y, Liu C, Ko P, Wang H, Hsiao L, Chiou T, Liu J, Gau J. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Journal of Microbiology, Immunology and Infection 2019;52:973-82. [DOI: 10.1016/j.jmii.2018.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
567 Garcia-Giraldo AM, Mora BL, Loaiza-Castaño JM, Cedano JA, Rosso F. Invasive fungal infection by Aspergillus flavus in immunocompetent hosts: A case series and literature review. Med Mycol Case Rep 2019;23:12-5. [PMID: 30450275 DOI: 10.1016/j.mmcr.2018.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
568 Lund B, Åsberg A, Heyman M, Kanerva J, Harila-saari A, Hasle H, Söderhäll S, Jónsson ÓG, Lydersen S, Schmiegelow K; On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO). Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia: Treatment Related Death in ALL. Pediatr Blood Cancer 2011;56:551-9. [DOI: 10.1002/pbc.22719] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
569 Beltrame A, Sarmati L, Cudillo L, Cerretti R, Picardi A, Anemona L, Fontana C, Andreoni M, Arcese W. A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. Int J Infect Dis 2009;13:e488-92. [PMID: 19386530 DOI: 10.1016/j.ijid.2009.01.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
570 Golan Y. Overview of transplant mycology. American Journal of Health-System Pharmacy 2005;62:S17-21. [DOI: 10.1093/ajhp/62.suppl_1.s17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
571 Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infectious Disease Clinics of North America 2016;30:143-63. [DOI: 10.1016/j.idc.2015.10.011] [Cited by in Crossref: 87] [Cited by in F6Publishing: 62] [Article Influence: 17.4] [Reference Citation Analysis]
572 Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis RE. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2006;50:469-473. [PMID: 16436698 DOI: 10.1128/AAC.50.2.469-473.2006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
573 Zedek DC, Miller MB. Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period. J Clin Microbiol 2006;44:1601. [PMID: 16597909 DOI: 10.1128/JCM.44.4.1601.2006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
574 Mullen CA, Abd. El-baki H, Samir H, Tarrand JJ, Rolston KV. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer 2003;11:321-5. [DOI: 10.1007/s00520-003-0453-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
575 Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis 2013;26:508-15. [PMID: 24126718 DOI: 10.1097/QCO.0000000000000008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 23] [Article Influence: 8.1] [Reference Citation Analysis]
576 Baddley JW, Moser SA. Emerging fungal resistance. Clinics in Laboratory Medicine 2004;24:721-35. [DOI: 10.1016/j.cll.2004.05.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
577 Vallabhaneni S, Benedict K, Derado G, Mody RK. Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013. Open Forum Infect Dis 2017;4:ofw268. [PMID: 28480260 DOI: 10.1093/ofid/ofw268] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
578 Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004;10 Suppl 1:67-75. [PMID: 14748803 DOI: 10.1111/j.1470-9465.2004.00845.x] [Cited by in Crossref: 220] [Cited by in F6Publishing: 153] [Article Influence: 12.9] [Reference Citation Analysis]
579 Marinach-Patrice C, Lethuillier A, Marly A, Brossas JY, Gené J, Symoens F, Datry A, Guarro J, Mazier D, Hennequin C. Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect 2009;15:634-42. [PMID: 19456834 DOI: 10.1111/j.1469-0691.2009.02758.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
580 Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-31. [PMID: 15472288 DOI: 10.1128/JCM.42.10.4419-4431.2004] [Cited by in Crossref: 467] [Cited by in F6Publishing: 139] [Article Influence: 27.5] [Reference Citation Analysis]
581 Paterson PJ, Seaton S, Mchugh TD, Mchugh J, Potter M, Prentice HG, Kibbler CC. Validation and Clinical Application of Molecular Methods for the Identification of Molds in Tissue. Clinical Infectious Diseases 2006;42:51-6. [DOI: 10.1086/498111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
582 Bow EJ. Considerations in the approach to invasive fungal infection in patients with haematological malignancies. Br J Haematol 2008;140:133-52. [PMID: 18173752 DOI: 10.1111/j.1365-2141.2007.06906.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
583 Deo SS, Virassamy B, Halliday C, Clancy L, Chen S, Meyer W, Sorrell TC, Gottlieb DJ. Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells. Cytotherapy 2016;18:65-79. [PMID: 26552765 DOI: 10.1016/j.jcyt.2015.09.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
584 Roman E, Osunkwo I, Militano O, Cooney E, van de Ven C, Cairo MS. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatr Blood Cancer 2008;50:325-30. [PMID: 17514732 DOI: 10.1002/pbc.21239] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
585 Hamdi A, Mulanovich VE, Matin SF, Landon G, Sircar K, Tu S, Nieto Y. Isolated Renal Mucormycosis in a Transplantation Recipient. JCO 2015;33:e50-1. [DOI: 10.1200/jco.2013.49.1969] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
586 Balkovec JM, Hughes DL, Masurekar PS, Sable CA, Schwartz RE, Singh SB. Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case study. Nat Prod Rep 2014;31:15-34. [PMID: 24270605 DOI: 10.1039/c3np70070d] [Cited by in Crossref: 81] [Cited by in F6Publishing: 30] [Article Influence: 11.6] [Reference Citation Analysis]
587 Liao M, Lin J, Li S. Application of a multiplex suspension array for rapid and simultaneous identification of clinically important mold pathogens. Molecular and Cellular Probes 2012;26:188-93. [DOI: 10.1016/j.mcp.2012.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
588 Galimberti R, Torre AC, Baztán MC, Rodriguez-Chiappetta F. Emerging systemic fungal infections. Clin Dermatol 2012;30:633-50. [PMID: 23068151 DOI: 10.1016/j.clindermatol.2012.01.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
589 Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, Jacobi V, Just-Nübling G, Bialek R. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007;44:1078-83. [PMID: 17366453 DOI: 10.1086/512812] [Cited by in Crossref: 146] [Cited by in F6Publishing: 97] [Article Influence: 10.4] [Reference Citation Analysis]
590 Alexander BD. Prophylaxis of invasive mycoses in solid organ transplantation: . Current Opinion in Infectious Diseases 2002;15:583-9. [DOI: 10.1097/00001432-200212000-00005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
591 Simitsopoulou M, Georgiadou E, Walsh TJ, Roilides E. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Med Mycol 2010;48:720-4. [DOI: 10.3109/13693780903476635] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
592 Maida CM, Milici ME, Trovato L, Oliveri S, Amodio E, Spreghini E, Scalise G, Barchiesi F. Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi. J Clin Microbiol 2008;46:4071-4. [PMID: 18923014 DOI: 10.1128/JCM.01088-08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
593 Wiederhold NP, Lewis JS. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Expert Opinion on Pharmacotherapy 2007;8:1155-66. [DOI: 10.1517/14656566.8.8.1155] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
594 Bhushan B, Homma T, Norton JE, Sha Q, Siebert J, Gupta DS, Schroeder JW Jr, Schleimer RP. Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus. Am J Respir Cell Mol Biol 2015;53:87-95. [PMID: 25474274 DOI: 10.1165/rcmb.2014-0333OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
595 Slesiona S, Gressler M, Mihlan M, Zaehle C, Schaller M, Barz D, Hube B, Jacobsen ID, Brock M. Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages. PLoS One 2012;7:e31223. [PMID: 22319619 DOI: 10.1371/journal.pone.0031223] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
596 Nichols WG. Management of infectious complications in the hematopoietic stem cell transplant recipient. J Intensive Care Med 2003;18:295-312. [PMID: 14984659 DOI: 10.1177/0885066603258009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
597 Maertens JA. History of the development of azole derivatives. Clin Microbiol Infect 2004;10 Suppl 1:1-10. [PMID: 14748798 DOI: 10.1111/j.1470-9465.2004.00841.x] [Cited by in Crossref: 201] [Cited by in F6Publishing: 137] [Article Influence: 11.8] [Reference Citation Analysis]
598 Klont RR, Mennink-kersten MASH, Verweij PE. Utility of Aspergillus Antigen Detection in Specimens Other than Serum Specimens. Clinical Infectious Diseases 2004;39:1467-74. [DOI: 10.1086/425317] [Cited by in Crossref: 139] [Cited by in F6Publishing: 92] [Article Influence: 8.2] [Reference Citation Analysis]
599 Camps IR. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. International Journal of Antimicrobial Agents 2008;32:S119-23. [DOI: 10.1016/s0924-8579(08)70012-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
600 Bow EJ. Of Yeasts and Hyphae: A Hematologist’s Approach to Antifungal Therapy. Hematology 2006;2006:361-7. [DOI: 10.1182/asheducation-2006.1.361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
601 Weng TF, Wu KH, Wu HP, Peng CT, Chao YH. Changes of serum aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis. Ital J Pediatr 2016;42:30. [PMID: 26960808 DOI: 10.1186/s13052-016-0239-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
602 Doffman SR, Agrawal SG, Brown JS. Invasive pulmonary aspergillosis. Expert Review of Anti-infective Therapy 2014;3:613-27. [DOI: 10.1586/14787210.3.4.613] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
603 Arif S, Perfect JR. Emergence of the Molds Other than Aspergillus in Immunocompromised Patients. Clin Chest Med 2017;38:555-73. [PMID: 28797495 DOI: 10.1016/j.ccm.2017.04.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
604 Garcia A, Vellanki S, Lee SC. Genetic tools for investigating Mucorales fungal pathogenesis. Curr Clin Microbiol Rep 2018;5:173-80. [PMID: 30574450 DOI: 10.1007/s40588-018-0097-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
605 Blyth CC, Hale K, Palasanthiran P, O'Brien T, Bennett MH. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010;:CD006343. [PMID: 20166083 DOI: 10.1002/14651858.CD006343.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
606 Drgona L, Colita A, Klimko N, Rahav G, Ozcan MA, Donnelly JP. Triggers for driving treatment of at-risk patients with invasive fungal disease. J Antimicrob Chemother. 2013;68 Suppl 3:iii17-iii24. [PMID: 24155142 DOI: 10.1093/jac/dkt391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
607 Steinbach WJ. New findings and unique aspects in pediatric aspergillosis. Med Mycol 2005;43:261-5. [DOI: 10.1080/13693780400025195] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
608 Behnsen J, Narang P, Hasenberg M, Gunzer F, Bilitewski U, Klippel N, Rohde M, Brock M, Brakhage AA, Gunzer M. Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathog 2007;3:e13. [PMID: 17274685 DOI: 10.1371/journal.ppat.0030013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
609 Alastruey-Izquierdo A, Hoffmann K, de Hoog GS, Rodriguez-Tudela JL, Voigt K, Bibashi E, Walther G. Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus). J Clin Microbiol 2010;48:2154-70. [PMID: 20357218 DOI: 10.1128/JCM.01744-09] [Cited by in Crossref: 80] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
610 Steinbach WJ, Cramer RA Jr, Perfect BZ, Asfaw YG, Sauer TC, Najvar LK, Kirkpatrick WR, Patterson TF, Benjamin DK Jr, Heitman J, Perfect JR. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 2006;5:1091-103. [PMID: 16835453 DOI: 10.1128/EC.00139-06] [Cited by in Crossref: 211] [Cited by in F6Publishing: 121] [Article Influence: 14.1] [Reference Citation Analysis]
611 Kasai M, Harrington SM, Francesconi A, Petraitis V, Petraitiene R, Beveridge MG, Knudsen T, Milanovich J, Cotton MP, Hughes J, Schaufele RL, Sein T, Bacher J, Murray PR, Kontoyiannis DP, Walsh TJ. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol 2008;46:3690-702. [PMID: 18845827 DOI: 10.1128/JCM.00917-08] [Cited by in Crossref: 77] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
612 Desoubeaux G, Bailly É, Chandenier J. Diagnosis of invasive pulmonary aspergillosis: Updates and recommendations. Médecine et Maladies Infectieuses 2014;44:89-101. [DOI: 10.1016/j.medmal.2013.11.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
613 Bruno C, Minniti S, Vassanelli A, Pozzi-Mucelli R. Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients. J Thorac Imaging 2007;22:160-5. [PMID: 17527120 DOI: 10.1097/RTI.0b013e31805f6a42] [Cited by in Crossref: 40] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
614 Liu H, Gravelat FN, Chiang LY, Chen D, Vanier G, Ejzykowicz DE, Ibrahim AS, Nierman WC, Sheppard DC, Filler SG. Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis. Mol Microbiol 2010;78:1038-54. [PMID: 21062375 DOI: 10.1111/j.1365-2958.2010.07389.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
615 Caira M, Girmenia C, Fadda RM, Mitra ME, Picardi M, Van Lint MT, Nosari A, Candoni A, Bonini A, Mattei D, de Waure C, Fianchi L, Valentini CG, Aversa F, Leone G, Pagano L. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk? Eur J Haematol 2008;81:242-3. [PMID: 18485113 DOI: 10.1111/j.1600-0609.2008.01096.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
616 Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20:581-607, vi. [PMID: 16984870 DOI: 10.1016/j.idc.2006.06.003] [Cited by in Crossref: 159] [Cited by in F6Publishing: 113] [Article Influence: 11.4] [Reference Citation Analysis]
617 Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2006;38:127-34. [DOI: 10.1038/sj.bmt.1705418] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
618 Mayr A, Lass-Flörl C. Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature. Eur J Med Res 2011;16:153-7. [PMID: 21486729 DOI: 10.1186/2047-783x-16-4-153] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
619 Perkhofer S, Lass-flörl C. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert Opinion on Investigational Drugs 2009;18:1393-404. [DOI: 10.1517/13543780903160658] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
620 Gerber B, Guggenberger R, Fasler D, Nair G, Manz MG, Stussi G, Schanz U. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood 2012;120:2390-4. [DOI: 10.1182/blood-2012-01-403030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
621 Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey. Transpl Infect Dis 2008;10:106-9. [PMID: 17605727 DOI: 10.1111/j.1399-3062.2007.00264.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
622 Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, Fridkin SK, Park BJ. Comparison of the Use of Administrative Data and an Active System for Surveillance of Invasive Aspergillosis. Infect Control Hosp Epidemiol 2008;29:25-30. [DOI: 10.1086/524324] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
623 Florescu DF, Sandkovsky U. Fungal infections in intestinal and multivisceral transplant recipients. Current Opinion in Organ Transplantation 2015;20:295-302. [DOI: 10.1097/mot.0000000000000188] [Cited by in Crossref: 13] [Article Influence: 2.2] [Reference Citation Analysis]
624 Li DM, Xiu DR, Li RY, Samson R, De Hoog G, Wang DL. Aspergillus flavus myositis in a patient after liver transplantation: Aspergillus flavus myositis in a patient after liver transplantation. Clinical Transplantation 2008;22:508-11. [DOI: 10.1111/j.1399-0012.2008.00801.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
625 Bialek R, Konrad F, Kern J, Aepinus C, Cecenas L, Gonzalez GM, Just-Nübling G, Willinger B, Presterl E, Lass-Flörl C, Rickerts V. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005;58:1180-4. [PMID: 16254108 DOI: 10.1136/jcp.2004.024703] [Cited by in Crossref: 171] [Cited by in F6Publishing: 124] [Article Influence: 11.4] [Reference Citation Analysis]
626 Naggie S, Perfect JR. Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis. Clin Chest Med 2009;30:337-53, vii-viii. [PMID: 19375639 DOI: 10.1016/j.ccm.2009.02.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
627 Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013;98:492-504. [PMID: 22983580 DOI: 10.3324/haematol.2012.065110] [Cited by in Crossref: 194] [Cited by in F6Publishing: 127] [Article Influence: 21.6] [Reference Citation Analysis]
628 Gafa V, Remoli ME, Giacomini E, Gagliardi MC, Lande R, Severa M, Grillot R, Coccia EM. In vitro infection of human dendritic cells by Aspergillus fumigatus conidia triggers the secretion of chemokines for neutrophil and Th1 lymphocyte recruitment. Microbes Infect 2007;9:971-80. [PMID: 17556001 DOI: 10.1016/j.micinf.2007.03.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
629 Platzbecker U, Bornhäuser M, Germing U, Stumpf J, Scott BL, Kröger N, Schwerdtfeger R, Böhm A, Kobbe G, Theuser C, Rabitsch W, Valent P, Sorror ML, Ehninger G, Deeg HJ. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant 2008;14:1217-25. [PMID: 18940675 DOI: 10.1016/j.bbmt.2008.08.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 7.4] [Reference Citation Analysis]
630 Pagano L, Caira M, Falcucci P, Fianchi L. Fungal CNS infections in patients with hematologic malignancy. Expert Rev Anti Infect Ther 2005;3:775-85. [PMID: 16207169 DOI: 10.1586/14787210.3.5.775] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
631 Bow EJ. Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients. Med Mycol 2005;43:277-87. [DOI: 10.1080/13693780400019990] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
632 Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006. Clinical Infectious Diseases 2006;43:1580-4. [DOI: 10.1086/509579] [Cited by in Crossref: 117] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
633 Chen SCA, Sorrell TC. Antifungal agents. Medical Journal of Australia 2007;187:404-9. [DOI: 10.5694/j.1326-5377.2007.tb01313.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
634 Adam O, Merad M, Antoun S, Bourhis JH, Gachot B, Casiraghi O, Chachaty E. [Usefulness of panfungal PCR for the diagnosis of fungal infection in immunocompromised patients]. Pathol Biol (Paris) 2004;52:544-9. [PMID: 15531120 DOI: 10.1016/j.patbio.2004.07.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA, Nichols WG, Musher B, Corey L. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004;103:1527-33. [PMID: 14525770 DOI: 10.1182/blood-2003-08-2644] [Cited by in Crossref: 327] [Cited by in F6Publishing: 234] [Article Influence: 18.2] [Reference Citation Analysis]
636 Nucci M, Anaissie E. Emerging Fungi. Infectious Disease Clinics of North America 2006;20:563-79. [DOI: 10.1016/j.idc.2006.06.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
637 Leithauser M, Kahl C, Aepinus C, Prall F, Maruschke M, Riemer H, Wolff D, Jost K, Hilgendorf I, Freund M, Junghanss C. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation: Invasive zygomycosis in patients with GVHD. Transplant Infectious Disease 2010;12:251-7. [DOI: 10.1111/j.1399-3062.2009.00480.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
638 Li L, Ding G, Feng N, Wang M, Ho Y. Global stem cell research trend: Bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics 2009;80:39-58. [DOI: 10.1007/s11192-008-1939-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
639 Hsu DI, Nguyen M, Nguyen L, Law A, Wong-beringer A. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. Journal of Antimicrobial Chemotherapy 2010;65:1765-70. [DOI: 10.1093/jac/dkq216] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
640 Wang C, Zhan P, Wang L, Zeng R, Shen Y, Lv G, Li D, Deng S, Liu W. The application of laser microdissection in molecular detection and identification of aspergillus fumigatus from murine model of acute invasive pulmonary aspergillosis. Mycopathologia 2014;178:53-61. [PMID: 24973974 DOI: 10.1007/s11046-014-9777-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
641 Ruping MJGT, Heinz WJ, Kindo AJ, Rickerts V, Lass-florl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA. Forty-one recent cases of invasive zygomycosis from a global clinical registry. Journal of Antimicrobial Chemotherapy 2010;65:296-302. [DOI: 10.1093/jac/dkp430] [Cited by in Crossref: 118] [Cited by in F6Publishing: 94] [Article Influence: 9.8] [Reference Citation Analysis]
642 Takazono T, Tashiro M, Ota Y, Obata Y, Wakamura T, Miyazaki T, Nishino T, Izumikawa K. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Sci Rep 2020;10:15033. [PMID: 32929112 DOI: 10.1038/s41598-020-72135-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
643 Alvez F, Figueras C, Roselló E; Grupo de Trabajo de Infecciones Fúngicas de la Sociedad Española de Infectología Pediátrica. [Emerging invasive fungal infections]. An Pediatr (Barc) 2010;73:52.e1-6. [PMID: 20605753 DOI: 10.1016/j.anpedi.2010.04.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
644 Chen C, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, Wagner JL, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger WI, Deeg HJ, Martin PJ, Sanders JE, Storb R, Storek J, Wade J, Siadak M, Flowers MED, Sullivan KM. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:515-22. [DOI: 10.1038/sj.bmt.1704162] [Cited by in Crossref: 75] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
645 Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, Wilhelm S, Reuter S, Kern W, Südhoff T, Mörz H, Hehlmann R. Prospective clinical evaluation of a LightCyclerTM-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological: PCR and Serology in the Diagnosis of Invasive Aspergillosis. British Journal of Haematology 2004;125:196-202. [DOI: 10.1111/j.1365-2141.2004.04904.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 86] [Article Influence: 6.4] [Reference Citation Analysis]
646 Cornely OA, Meems L, Herbrecht R, Viscoli C, van Amsterdam RG, Ruhnke M. Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis. Mycoses 2015;58:58-64. [PMID: 25530265 DOI: 10.1111/myc.12274] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
647 Wiederhold NP, Lewis RE. The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Expert Opinion on Investigational Drugs 2005;12:1313-33. [DOI: 10.1517/13543784.12.8.1313] [Cited by in Crossref: 110] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
648 Machouart M, Larché J, Burton K, Collomb J, Maurer P, Cintrat A, Biava MF, Greciano S, Kuijpers AF, Contet-Audonneau N, de Hoog GS, Gérard A, Fortier B. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol 2006;44:805-10. [PMID: 16517858 DOI: 10.1128/JCM.44.3.805-810.2006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
649 Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007;45:305-20. [DOI: 10.1080/13693780701200372] [Cited by in Crossref: 170] [Cited by in F6Publishing: 109] [Article Influence: 12.1] [Reference Citation Analysis]
650 Mühlemann K, Wenger C, Zenhäusern R, Täuber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 2005;19:545-50. [DOI: 10.1038/sj.leu.2403674] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
651 Cheng VC, Chan JF, Ngan AH, To KK, Leung SY, Tsoi HW, Yam WC, Tai JW, Wong SS, Tse H, Li IW, Lau SK, Woo PC, Leung AY, Lie AK, Liang RH, Que TL, Ho PL, Yuen KY. Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 2009;47:2834-43. [PMID: 19641069 DOI: 10.1128/JCM.00908-09] [Cited by in Crossref: 87] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
652 Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005;43 Suppl 1:S49-58. [PMID: 16110792 DOI: 10.1080/13693780400020113] [Cited by in Crossref: 287] [Cited by in F6Publishing: 210] [Article Influence: 17.9] [Reference Citation Analysis]
653 Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Mcginnis MR, Ostrosky-zeichner L. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006;44:267-72. [DOI: 10.1080/13693780500474327] [Cited by in Crossref: 92] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
654 Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ; Caspofungin Salvage Aspergillosis Study Group. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004;39:1563-71. [PMID: 15578352 DOI: 10.1086/423381] [Cited by in Crossref: 495] [Cited by in F6Publishing: 334] [Article Influence: 29.1] [Reference Citation Analysis]
655 Sarina B, Mariotti J, Bramanti S, Morabito L, Crocchiolo R, Rimondo A, Tordato F, Pocaterra D, Casari E, De Philippis C, Carlo-Stella C, Santoro A, Castagna L. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling. Transpl Infect Dis 2018;20:e12906. [PMID: 29668124 DOI: 10.1111/tid.12906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
656 Guinea J, Bouza E. Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections. Future Microbiol 2008;3:603-15. [PMID: 19072177 DOI: 10.2217/17460913.3.6.603] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
657 Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, Wheat LJ, Wingard JR. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011;17:1043-50. [PMID: 21087680 DOI: 10.1016/j.bbmt.2010.11.013] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
658 Pak J, Tucci VT, Vincent AL, Sandin RL, Greene JN. Mucormycosis in immunochallenged patients. J Emerg Trauma Shock 2008;1:106-13. [PMID: 19561989 DOI: 10.4103/0974-2700.42203] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
659 Forrest G, Mankes K. Outcomes of invasive zygomycosis infections in renal transplant recipients. Transplant Infect Dis 2007;9:161-4. [DOI: 10.1111/j.1399-3062.2006.00197.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
660 Cesaro S, Cecchetto G, De Corti F, Dodero P, Giacchino M, Caviglia I, Fagioli F, Livadiotti S, Salin F, Caselli D, Castagnola E. Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients. Pediatr Blood Cancer 2006;49:909-13. [DOI: 10.1002/pbc.21089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
661 Strasfeld L, Weinstock DM. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents. Expert Review of Anti-infective Therapy 2014;4:457-68. [DOI: 10.1586/14787210.4.3.457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
662 Kim R, Khachikian D, Reboli AC. A comparative evaluation of properties and clinical efficacy of the echinocandins. Expert Opinion on Pharmacotherapy 2007;8:1479-92. [DOI: 10.1517/14656566.8.10.1479] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
663 Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients: . Current Opinion in Oncology 2005;17:89-92. [DOI: 10.1097/01.cco.0000152975.65477.7c] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
664 Stein MK, Karri S, Reynolds J, Owsley J, Wise A, Martin MG, Zare F. Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib. World J Oncol 2018;9:62-5. [PMID: 29760835 DOI: 10.14740/wjon1099w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
665 Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-163. [PMID: 17223626 DOI: 10.1128/cmr.00029-06] [Cited by in Crossref: 2555] [Cited by in F6Publishing: 1049] [Article Influence: 182.5] [Reference Citation Analysis]
666 Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination Antifungal Therapy for Invasive Aspergillosis. Clinical Infectious Diseases 2004;39:797-802. [DOI: 10.1086/423380] [Cited by in Crossref: 458] [Cited by in F6Publishing: 297] [Article Influence: 26.9] [Reference Citation Analysis]
667 Tischler BY, Hohl TM. Menacing Mold: Recent Advances in Aspergillus Pathogenesis and Host Defense. J Mol Biol 2019;431:4229-46. [PMID: 30954573 DOI: 10.1016/j.jmb.2019.03.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
668 Torres H, Raad I, Kontoyiannis D. Infections Caused by Fusarium Species. Journal of Chemotherapy 2013;15:28-35. [DOI: 10.1179/joc.2003.15.supplement-2.28] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
669 Li Y, Xu W, Jiang Z, Gao Y, Pang Y, Li L, OuYang L, Zhang L, Liu Z, Wang Y, Xiao Y, Huang X. Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China. Tumour Biol 2014;35:5869-76. [PMID: 24664582 DOI: 10.1007/s13277-014-1777-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
670 Richardson M, Lass-flörl C. Changing epidemiology of systemic fungal infections. Clinical Microbiology and Infection 2008;14:5-24. [DOI: 10.1111/j.1469-0691.2008.01978.x] [Cited by in Crossref: 294] [Cited by in F6Publishing: 222] [Article Influence: 22.6] [Reference Citation Analysis]
671 Lass-Flörl C, Cuenca-Estrella M, Denning DW, Rodriguez-Tudela JL. Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology. Med Mycol 2006;44:S319-25. [PMID: 30408924 DOI: 10.1080/13693780600779401] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
672 Edelstein SL, Akduman L, Durham BH, Fothergill AW, Hsu HY. Resistant Fusarium keratitis progressing to endophthalmitis. Eye Contact Lens 2012;38:331-5. [PMID: 21993589 DOI: 10.1097/ICL.0b013e318235c5af] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
673 Devlin SM, Hu B, Ippoliti A. Mucormycosis Presenting as Recurrent Gastric Perforation in a Patient with Crohn’s Disease on Glucocorticoid, 6-Mercaptopurine, and Infliximab Therapy. Dig Dis Sci 2007;52:2078-81. [DOI: 10.1007/s10620-006-9455-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
674 Kauffman CA, Nicolasora NP. Epidemiology of Invasive Pulmonary Aspergillosis. In: Comarú Pasqualotto A, editor. Aspergillosis: From Diagnosis to Prevention. Dordrecht: Springer Netherlands; 2010. pp. 329-44. [DOI: 10.1007/978-90-481-2408-4_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
675 Ellis M. Febrile neutropenia. Ann N Y Acad Sci 2008;1138:329-50. [PMID: 18837909 DOI: 10.1196/annals.1414.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
676 Spellberg B, Maertens J. Mucormycosis. In: Safdar A, editor. Principles and Practice of Transplant Infectious Diseases. New York: Springer; 2019. pp. 577-89. [DOI: 10.1007/978-1-4939-9034-4_34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
677 Van Thiel DH, George M, Moore CM. Fungal infections: their diagnosis and treatment in transplant recipients. Int J Hepatol 2012;2012:106923. [PMID: 22966464 DOI: 10.1155/2012/106923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
678 Wisniewski T, Klimko N, Laverdiere M, Kiertiburanakul S, Kliasova G, Trenschel R, Kumar RN. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA): Caspofungin therapy in invasive aspergillosis. Mycoses 2011;54:e148-53. [DOI: 10.1111/j.1439-0507.2010.01861.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
679 Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C; for the Infectious Diseases Group of the EORTC. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 2010;45:1227-33. [DOI: 10.1038/bmt.2009.334] [Cited by in Crossref: 104] [Cited by in F6Publishing: 74] [Article Influence: 9.5] [Reference Citation Analysis]
680 Lionakis M, Bodey G, Tarrand J, Raad I, Kontoyiannis D. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clinical Microbiology and Infection 2004;10:922-5. [DOI: 10.1111/j.1469-0691.2004.00933.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [